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Deficiency and insufficiency of vitamin D (VitD) affect populations worldwide. It is a 
major health problem in Saudi Arabia. Inadequate VitD3 status has been associated with several 
chronic disease conditions such as diabetes, autoimmune disease, infectious disease, cancer, and 
cardiovascular disease, most of which are present in the Saudi Arabian population. Fortification 
of foods with VitD3 has been present for decades; however, its stability in foods is often 
compromised by its rapid degradation, low absorption, and poor water solubility. Nano-
encapsulation technologies could prove useful to address the shortcomings of current 
fortification vehicles. 
In this study, soy protein isolate was conditioned using pH shifting and ultrasound 
sonication treatment to create soy protein-based nanoemulsions (SPNEs). The SPNEs were 
loaded with VitD3 and evaluated in terms of stability, bioaccessibility, bioavailability, 
bioefficacy, sensory, and physicochemical effects. VitD3 stability was evaluated after UV-B light 
exposure for 0, 30, 60 and 120 min followed by quantification using and reversed phase HPLC-
UV. Bioaccessibility was evaluated in a two-compartment in vitro digestion model. 
Bioavailability was studied using an animal model of (n=114 rats), in which three groups were 
compared: SPNEs+VitD3 (2 mL, 150 µg/mL), VitD3 in oil (0.5 mL, 300 µg/mL), and oil without 
VitD3 (0.6 mL canola oil). The physicochemical characteristics of drinkable yogurt with 
SPNEs+VitD3 were evaluated against an unfortified control in terms of pH, color changes, 
viscosity, and titratable acidity. For sensory evaluation, a triangle test was used, in which adult 
participants (n=62) had to identify the odd sample. Samples were drinkable yogurt fortified with 
SPNEs+VitD3 (4.2 µg VitD3/100 mL, 30% RDA adults) and their unfortified counterparts. 




which three groups of participants with VitD3 insufficiency received: placebo (drinkable yogurt), 
VitD3 control in drinkable yogurt (4,000 IU), and VitD3 in SPNEs (4,000 IU) dispersed in 
drinkable yogurt. Also, the lifestyle behaviors associated with low VitD3 status were evaluated 
using a VitD questionnaire. 
Results indicated that the reduction in particle size and dispersion of VitD3 in SPNEs 
protects VitD3 from UV-B exposure and increases its bioaccessibility and oral bioavailability. 
The addition of VitD3 in SPNEs did not influence the physicochemical properties and sensory 
attributes of fortified drinkable yogurt. The consumption of SPNEs+VitD3 dispersed in drinkable 
yogurt increased the circulating levels of 25(OH)D3 in subjects with VitD3 insufficiency, more so 
than the traditional therapy. The application of a validated questionnaire on lifestyle behaviors 
associated with the potential risk for VitD deficiency and insufficiency was not instrumental in 
identifying behaviors associated with low VitD3 status. In conclusion, the encapsulation of VitD3 
in SPNEs is a promising approach to address VitD3 gaps among at-risk populations via the food 
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CHAPTER 1: INTRODUCTION 
Vitamin D and Health 
Vitamin D (VitD3 or cholecalciferol) is an essential fat-soluble vitamin required in 
promoting bone health, regulating blood calcium levels, and its deficiency is associated with 
several diseases and conditions (Holick & Chen, 2008). VitD3 has been associated with the 
function of organs and pathogenesis of several disease conditions such as muscle physiology 
(Boland, 1986), certain cancers (Grant, 2018), diabetes (Altieri et al., 2017), multiple sclerosis 
(Summerday, Brown, Allington, & Rivey, 2012), and cardiovascular disease (Al Mheid & 
Quyyumi, 2017), among others. Cholecalciferol or VitD3 is formed in the skin from 7-
dehydrocholesterol, but also could be synthesized through UV irradiation of lanolin. Ergocalciferol 
or VitD2 is obtained by UV irradiation of ergosterol from the yeast. In liver, VitD3 metabolized to 
its circulating form, 25(OH)D3, by the enzyme VitD-25-hydroxylase. Its hormonal or active form 
is created in the kidney, where the circulating form is activated to 1, 25(OH)2D by the enzyme 
25(OH)D-1-hydroxylase. There are many factors regulating VitD3 activation, the most 
important are Ca, P, and PTH levels (Tsiaras & Weinstock, 2011).  
 The definition of sufficient, insufficient, and deficient serum levels of VitD3 is different 
worldwide. Vitamin D deficiency (VitDD) is defined at a cutoff of 20 ng/mL in serum (multiply 
by 2.5 to convert to nmol/L). Although under debate, the VitD3 insufficiency range is recognized 
from 21-29 ng/mL (Holick et al., 2011). The normal range of VitD3 varies from 30-100 ng/mL, 
with a preferred range between 30-60 ng/mL (Holick, 2007). The US Institute of Medicine (IOM 
2011) defines deficiency at a serum level of 25(OH)D3 below 12 ng/mL and insufficiency at a 





cutoffs for the diagnosis of VitD3 status. Low VitD3 status or hypovitaminosis D, for example, 
was reported at circulating 25(OH)D3 of less than 39 ng/mL (Elsammak, Al-Wossaibi, Al-
Howeish, & Alsaeed, 2011), less than 30 ng/mL  (Abdelkarem, El-Sherif, & Gomaa, 2016; Al-
Elq, 2012; Al-Mogbel, 2012; Al-Turki, Sadat-Ali, Al-Elq, Al-Mulhim, & Al-Ali, 2008; Ali, 
Amin, & AlAli, 2012; Alsuwaida, Frcp, Farag, Sayyari, & Frcp, 2013; Ardawi, Qari, Rouzi, 
Maimani, & Raddadi, 2011a) and less than 20 ng/mL (Al-Daghri, Al-Saleh, et al., 2015; Al-
Daghri, Aljohani, et al., 2015). This discrepancy in the cut-off used accounts for the different and 
seemingly high rates of VitDD and insufficiency reported from Middle Eastern countries.  
Food fortification of staples is one of the most effective strategies to deliver and maintain 
adequate nutrition to the population at large, especially to those at-risk groups (Allen, de Benoist, 
Dary, & Hurrell, 2006). In Saudi Arabia, VitD3 deficiency and insufficiency are prevalent, 
especially among women and young children (N. A. Al Jurayyan, Mohamed, A Al Issa, & Al 
Jurayyan, 2012; AlBuhairan et al., 2015; Ardawi, Qari, Rouzi, Maimani, & Raddadi, 2011b). To 
address these nutrient gaps, several food products are fortified with micronutrients such as iron, 
niacin, folic acid, vitamin A and VitD3. Although available products could provide excellent 
nutrition to populations, many products do not address the physiological status of individuals, their 
cultural habits, and socio-economic conditions. Moreover, most food vehicles that deliver VitD3 
are based on fluid milk. Some population groups might not consume it due to lactose intolerance 
and other preferences. Thus, new technologies should overcome the shortcomings of current 
products and thus improve the diversity of offerings via food vehicles that could prove useful to 
improve VitD3 status among populations. 
Delivering adequate nutrition to specific groups and facilitating functional food access to a 





bioactives and nutrients, however, is not a straightforward process. Bringing new ingredients into a 
food recipe often leads to food deterioration and rapid spoilage, changes in rheology, modifications 
in sensory attributes, changes in consumption habits and preparation, and interactions with other 
food ingredients; thereby reducing the intended beneficial effect. The technical feasibility of the 
chosen product and the fortificant are some of the many factors that determine the success of the 
fortification process, which includes the level of fortification, the consumption pattern, the 
interactions among nutrients, the stability of premixes, and the physicochemical changes that 
could affect final product’s quality (Allen et al., 2006). 
Nanotechnology has become a valuable application in the biomedical field, and 
nanocarrier formulations have proved useful for many clinical therapies in cancer chemotherapy 
(Nishiyama, 2007). The applications of nanotechnology in food science are attracting much 
interest in designing effective delivery systems for bioactive compounds to improve their 
chemical, physical, oxidative stabilities, solubility, prevent them from degradation, and thus 
increase the oral bioavailability Oil-in-water nanoemulsions are good delivery vehicles for 
delivering and the fat-soluble bioactives as they can successfully be incorporated into beverages 
due to their transparent appearance (Öztürk, 2017a).  
 
Long-term Goal, Research Objective, and Hypothesis 
In this dissertation work, the long-term goal was to improve micronutrient nutrition in 
low-income settings by offering alternative delivery technologies that better address the needs of 
vulnerable populations within the context of their food system. The main objective was to 





drink and evaluate the bioavailability and bioefficacy of the nanoemulsions containing VitD3 in 
vivo. The central hypothesis was that the reduction of the particle size of VitD3 by dispersing it in 
SPNEs will enable its compatibility with foods while increasing its absorption to a greater extent 
than the conventional therapy in subjects with marginal VitDD as evaluated in animal and human 
studies. 
The plan was to test the central hypothesis and, thereby, accomplish the objective of this 
application by pursuing the following three specific aims: 
Specific Aim 1. Evaluate the ability of soy protein isolates (SPI)-based nanoemulsions to 
improve stability, bioaccessibility, and bioavailability of VitD3 dispersed in SPNEs. 
The working hypothesis was that the dispersion of VitD3 in SPNEs will improve its stability, 
bioaccessibility, and increase the oral bioavailability as evaluated in adult rats using a high dose 
of cholecalciferol. 
Specific Aim 2. Evaluate the bioefficacy of SPNEs containing VitD3 dispersed in drinkable yogurt 
to improve circulating serum 25(OH)D3 status in patients with VitD3 insufficiency and explore the 
association of lifestyle behaviors such as sun exposure, use of tanning booth and sunscreen, 
specific dietary habits, and BMI and fat mass with VitD3 insufficiency in adult Saudi Arabian 
populations. 
For this aim, the first working hypothesis was that a two-week treatment with a drinkable yogurt 
fortified with SPNEs containing VitD3 (100 µg/100mL) three times a week will increase serum 
25(OH)D3 higher than a traditional therapy as evaluated in a cohort of adult subjects diagnosed 
with VitD3 insufficiency. The second working hypothesis was that the lifestyle behaviors such as 





multivitamins VitD supplements), UV exposure habits (i. e., tan in the past 12 months, tanning 
booth, sunscreen, sun exposure time, sun exposure duration), as well as percentage of body fat 
mass (BFM%), and body mass index (BMI) are associated with VitD3 insufficiency. 
Specific Aim 3. Evaluate the effect of fortification with VitD3 dispersed in SPNEs on the 
physicochemical and sensory properties of drinkable yogurt. 
The working hypothesis was drinkable yogurt fortified with VitD3 dispersed in SPNEs will be similar 
to an unfortified control in terms of its sensory characteristics (i.e., discrimination test with adults) 
as well as its physicochemical properties (i.e., pH, color, titratable acidity, and viscosity), which were 
evaluated under a combination of temperature (4 and 23 °C) and time (0-2 days). 
 
Research Significance and Rationale 
Improving delivery of VitD3 to at-risk populations is a public health concern. 
Stabilization and dispersion of fat-soluble vitamins such as VitD3 in aqueous food systems is a 
challenge for the food industry. Moreover, the delivery of VitD3 in foods in response to the 
prevalence of VitDD among Saudi Arabian populations to increase the uptake of VitD3, and thus, 
disease prevention presents additional challenges beyond increasing its amount in foods. Current 
strategies are limited in their ability to enhance the absorption of VitD3 and, at the same time, 
offer stable delivery in aqueous food systems, protection from UV-B light, and reduction of 
unexpected physicochemical changes that might affect consumption. Although the encapsulation 
delivery systems are commercially available and are suitable technologies for the delivery of 
many forms of bioactives and flavors, there still is a need to develop micronutrient delivery 





was that the physicochemical conditioning of soy protein, an abundant and inexpensive wall 
material, via pH-shifting and ultrasonication will create protein-based nanoemulsions containing 
VitD3, which can stabilize the vitamin in the nano range and thus better address these identified 
hurdles, including its behavior in foods as well as its absorption. These benefits can be translated 
into a vitamin-delivery system that has limited effects on the final aqueous food matrices. This 
dissertation work will provide an evidence-based framework that could be used to develop a 
tailored portfolio of micronutrient delivery vehicles for populations around the world. 
The research studies have basic and applied significance in SPNEs research and 
development in global health. In the field of SPNEs, these studies will provide a basis for 
systematic development, characterization, and optimization of SPNEs containing VitD3 with a 
focus on a target population. Also, these studies will contribute to our limited knowledge of the use 
of SPNEs containing VitD3 in foods to treat specific population. In global health, these studies will 
expand the ability to create functional SPNEs containing products that can include nutrients and 
bioactives that better address nutrient gaps worldwide as well as to instigate interest of 
stakeholders to further the research in the area of functional SPNEs. 
 
Thesis Structure 
The thesis is organized into six chapters. Chapter 1 and Chapter 2 are composed of an 
introduction to the thesis and a detailed literature review, respectively, which provide a 
background of each area of research relevant to the dissertation research included herein. This 
information gives the reader sufficient background knowledge to understand the theoretical basis 





nanoemulsions to improve stability, bioaccessibility, and bioavailability of VitD3 dispersed in 
SPNEs. These data from Chapter 3 partially satisfy Aim 1 and provide a basic formula for 
further studies. The research in Chapter 4 describes the bioefficacy of SPNEs containing VitD3 
dispersed in drinkable yogurt to improve the circulating 25(OH)D3 status in subjects with VitD3 
insufficiency and identify which lifestyle behaviors are associated with a higher risk of VitD3 
insufficiency among adult Saudi Arabian populations. These data will be instrumental in testing 
the working hypothesis of Aim 2 and provides a basis for extrapolation of an effective dose of 
SPNEs containing VitD3 dispersed in drinkable yogurt. Chapter 5 contributes to completing the 
overall objective of this dissertation by evaluating the sensory difference between two products 
(fortified drinkable yogurt with SPNEs containing VitD3 vs. control) and to evaluate the quality 
characteristics including viscosity, acidity, pH, and colors differences during temperature and 
storage time. Chapter 6 summarizes the findings from each of the previous chapters and 














Abdelkarem, H. M., El-Sherif, M. A., & Gomaa, S. B. (2016). Vitamin D status and insulin 
resistance among young obese saudi females. Saudi Medical Journal, 37(5), 561–566. 
https://doi.org/10.15537/smj.2016.5.13581 
Al-Daghri, N. M., Al-Saleh, Y., Aljohani, N., Alokail, M., Al-Attas, O., Alnaami, A. M., … 
Chrousos, G. P. (2015). Vitamin D deficiency and cardiometabolic risks: A juxtaposition of 
arab adolescents and adults. PLoS ONE, 10(7), 1–11. 
https://doi.org/10.1371/journal.pone.0131315 
Al-Daghri, N. M., Aljohani, N., Al-Attas, O. S., Krishnaswamy, S., Alfawaz, H., Al-Ajlan, A., & 
Alokail, M. S. (2015). Dairy products consumption and serum 25-hydroxyvitamin. 
International Journal of Clinical and Experimental Pathology, 8(7), 8480–8486. 
https://doi.org/10.1021/acs.jnatprod.7b00625 
Al-Elq, A. (2012). The status of Vitamin D in medical students in the preclerkship years of a 
Saudi medical school. Journal of Family and Community Medicine, 19(2), 100. 
https://doi.org/10.4103/2230-8229.98293 
Al-Mogbel, E. S. (2012). Vitamin D status among Adult Saudi Females visiting Primary Health 
Care Clinics. International Journal of Health Sciences, 6(2), 116–126. 
https://doi.org/10.12816/0005987 
Al-Turki, H. A., Sadat-Ali, M., Al-Elq, A. H., Al-Mulhim, F. A., & Al-Ali, A. K. (2008). 25-
Hydoxyvitamin D levels among healthy Saudi Arabian women. Saudi Medical Journal, 
29(12), 1765–1768. https://doi.org/20080715’ [pii] 
AlBuhairan, F. S., Tamim, H., Al Dubayee, M., Aldhukair, S., Al Shehri, S., Tamimi, W., … Al 
Alwan, I. (2015). Time for an Adolescent Health Surveillance System in Saudi Arabia: 
Findings from “jeeluna.” Journal of Adolescent Health, 57(3), 263–269. 
https://doi.org/10.1016/j.jadohealth.2015.06.009 
Ali, A., Amin, L., & Al-Ali, A. (2012). Vitamin D level Among Female Students in College of 
Nursing in Saudi Arabia and its Relation to Students’ Symptoms. Journal of American 
Science, 8(11), 132–138. 
AlJurayyan, N. A., Mohamed, S., AlIssa, S. D. ., & AlJurayyan, A. N. . (2012). Rickets and 
osteomalacia in Saudi children and adolescents attending endocrine clinic, Riyadh, Saudi 
Arabia. Sudanese Journal of Pediatrics, 12, 56–63. Retrieved from http://www.sudanjp.org 
Allen, L., de Benoist, B., Dary, O., & Hurrell, R. (2006). Guidelines on food fortification with 
micronutrients. Geneva, Switzerland. 
Alsuwaida, A. O., Farag, Y. M., Al Sayyari, A. A., Mousa, D. H., Alhejaili, F. F., Al-Harbi, A. 
S., … Singh, A. K. (2013). Prevalence of vitamin D deficiency in Saudi adults. Saudi Med 
J, 34(8), 814–818. 
Altieri, B., Grant, W. B., Della Casa, S., Orio, F., Pontecorvi, A., Colao, A., … Muscogiuri, G. 





diabetes mellitus and pancreatic cancer. Critical Reviews in Food Science and Nutrition, 
57(16), 3472–3488. https://doi.org/10.1080/10408398.2015.1136922 
Ardawi, M. S. M., Qari, M. H., Rouzi, A. A., Maimani, A. A., & Raddadi, R. M. (2011a). 
Vitamin D status in relation to obesity, bone mineral density, bone turnover markers and 
vitamin D receptor genotypes in healthy Saudi pre- and postmenopausal women. 
Osteoporosis International. https://doi.org/10.1007/s00198-010-1249-7 
Ardawi, M. S. M., Qari, M. H., Rouzi, A. A., Maimani, A. A., & Raddadi, R. M. (2011b). 
Vitamin D status in relation to obesity, bone mineral density, bone turnover markers and 
vitamin D receptor genotypes in healthy Saudi pre- and postmenopausal women. 
Osteoporosis International, 22(2), 463–475. https://doi.org/10.1007/s00198-010-1249-7 
Boland, R. L. (1986). Plants as a Source of Medicine. Medicinal & Aromatic Plants, s3(I). 
https://doi.org/10.4172/2167-0412.S3-e001 
Elsammak, M. Y., Al-Wossaibi, A. A., Al-Howeish, A., & Alsaeed, J. (2011). High prevalence 
of vitamin D deficiency in the sunny Eastern region of Saudi Arabia: a hospital-based study. 
Eastern Mediterranean Health Journal, 17(4), 317–322. https://doi.org/10.1016/0167-
8116(91)90010-5 
Grant, W. B. (2018). A Review of the Evidence Supporting the Vitamin D-Cancer Prevention 
Hypothesis in 2017. Anticancer Research, 38(2), 1121–1136. 
https://doi.org/10.21873/anticanres.12331 
Holick, M. F. (2007). Vitamin D deficiency. The New England Journal of Medicine, 357(3), 
266–281. 
Holick, M. F., Binkley, N. C., Bischoff-Ferrari, H. A., Gordon, C. M., Hanley, D. A., Heaney, R. 
P., … Weaver, C. M. (2011). Evaluation, treatment, and prevention of vitamin D 
deficiency: An endocrine society clinical practice guideline. Journal of Clinical 
Endocrinology and Metabolism. https://doi.org/10.1210/jc.2011-0385 
Holick, M. F., & Chen, T. C. (2008). Vitamin D deficiency: a worldwide problem with health 
consequences. American Journal of Clinical Nutrition, 87(4), 1080S–6S. 
https://doi.org/87/4/1080S [pii] 
Sloan, E., & Hutt, C. A. (2012). Beverage trends in 2012 and beyond. Agro Food Industry Hi-
Tech, 23(4), 8–12. 
Summerday, N. M., Brown, S. J., Allington, D. R., & Rivey, M. P. (2012). Vitamin D and 
multiple sclerosis: Review of a possible association. Journal of Pharmacy Practice, 25(1), 
75–84. https://doi.org/10.1177/0897190011421839 
Temmerman, J. C. (2011). Vitamin D and Cardiovascular Disease. Journal of the American 
College of Cardiology, 30(3), 167–170. https://doi.org/10.1016/j.jacc.2017.05.031 
Tsiaras, W. G., & Weinstock, M. A. (2011). Factors influencing vitamin D status. Acta Dermato-






CHAPTER 2: LITERATURE REVIEW 
Vitamin D Deficiency 
Vitamin D (VitD3 or cholecalciferol) is an essential fat-soluble vitamin required in 
promoting bone health, regulating blood calcium levels, and its deficiency related to many 
diseases and conditions such as autoimmune, cancer, diabetes mellitus, hypertension and 
infectious diseases (Holick & Chen, 2008). VitD3 has been associated with the function of organs 
and pathogenesis of several disease conditions such as muscle physiology (Boland, 1986), certain 
cancers (Grant, 2018), diabetes (Altieri et al., 2017), multiple sclerosis (Summerday et al., 2012), 
and cardiovascular disease (Al Mheid & Quyyumi, 2017), among others. Cholecalciferol or VitD3 
is formed in the skin from 7-dehydrocholesterol, but also could be synthesized through UV 
irradiation of lanolin. Ergocalciferol or VitD2 is obtained by UV irradiation of ergosterol from the 
yeast. In liver, VitD3 metabolized to its circulating form, 25(OH)D3, by the enzyme VitD-25-
hydroxylase. Its hormonal or active form occurs in the kidney, where the circulating form is 
activated to 1, 25(OH)D2 by the enzyme 25(OH)D-1-hydroxylase. There are many factors 
regulating VitD3 activation, the most important are Ca, P, and PTH levels (Tsiaras & Weinstock, 
2011).  
The definition of sufficient, insufficient, and deficient serum levels of VitD3 is different 
worldwide. Vitamin D deficiency (VitDD) is defined at a cutoff of 20 ng/mL in serum (multiply 
by 2.5 to convert to nmol/L). Although under debate, the VitD3 insufficiency range is recognized 
from 21-29 ng/mL (Holick et al., 2011). The normal range of VitD3 varies from 30-100 ng/mL, 
with a preferred range between 30-60 ng/mL (Holick, 2007). The US Institute of Medicine (IOM 





serum level between 12–20 ng/mL. In Saudi Arabia, scientists have invariably used different 
cutoffs for the diagnosis of VitD3 status. Low VitD3 status or hypovitaminosis D, for example, 
was reported at circulating 25(OH)D3 of less than 39 ng/mL (Elsammak et al., 2011), less than 
30 ng/mL (Abdelkarem et al., 2016; Al-Elq, 2012; Al-Mogbel, 2012; Al-Turki et al., 2008; Ali et 
al., 2012; Alsuwaida et al., 2013; Ardawi et al., 2011a) and less than 20 ng/mL (Al-Daghri, Al-
Saleh, et al., 2015; Al-Daghri, Aljohani, et al., 2015). This discrepancy in the cutoff used 
accounts for the different and seemingly high rates of VitDD and insufficiency reported from 
Middle Eastern countries.   
The prevalence of VitDD is greater in morbidly obese patients compare to those with 
normal body weight. In a recent meta-analysis, VitDD among morbidly obese was 35% greater 
than in those subjects with normal BMI. This might be due to a decreased hepatic synthesis of 
25(OH)D3 as a result of pro-inflammatory cytokines, decreased exposure to sunlight, and trapped 
VitD3 in adipose tissue (Miñambres, Sanchez-Quesada, & Pérez, 2015). Other factors that might 
influence circulating VitD3 levels are body fat mass, sex, and sun exposure. In a recent study with 
370 adults (18-55 years) in Brazil, Pesarini et al., (2017) showed that close to 80% of the 
participants had 25(OH)D3 at or below the cutoff (30 ng/mL). The multivariate linear regression 
model showed that age (β=−0.076; P=0.02), BMI (β=−0.213; P = 0.01), HDL (β=−0.104, P < 
0.001), blood glucose (β=0.108; P = 0.02) and reduced sun exposure (β=−2.593; P < 0.001) were 
all predictive of low VitD3 levels. In another study, Lenders et al., (2009) showed that body fat 
mass % was significantly higher in the VitDD group than in the VitD3 sufficient group (r=-0.26; P 
= <0.05). They concluded that this association might be subject to metabolic factors. In Saudi 







Vitamin D deficiency in Saudi Arabia. With the advent of improved food fortification 
technologies, the prevalence of rickets in the western hemisphere has been virtually eradicated. This 
has not been a problem for the Middle East region. Although sunlight exposure (i.e., UV-B 
irradiation) results in plenty of VitD3 syntheses throughout the year and that adequate sunlight is 
available in Middle Eastern countries (located within longitudes 20o and 40o N), recent reports 
describe some of the highest rates of rickets in the world. Although large prospective population-
based studies are limited, some inferences could be obtained from a few cross-sectional and clinical 
trials.  
In a small retrospective study, AlJurayyan et al., (2012) found that from January 1990 to 
December 2009 the prevalence of rickets was 68% among 85 Saudi children and adolescences (2-
18 years) living Riyadh. This was in large extent explained by the reduced sunlight exposure, cultural 
practices, skin coloration, and limited calcium intake. In another cohort study, Erfan, Nafie, Neyaz, 
& Hassanein, (1997) found that maternal VitDD was strongly associated with rickets in infants. 
Moreover, lack of sunlight exposure and exclusive breastfeeding (i.e., from VitDD lactating 
mothers) were the underlining causes of VitDD among a cohort of 61 infants in Riyadh (Al-mustafa, 
Al-madan, & Al-majid, 2007). Rickets was associated with both limited sunlight exposure and low 
dietary calcium in two other studies of children and adolescents (Abdullah et al., 2002; Al-Jurayyan 
et al., 2012). A recent report from a clinical study in Saudi Arabia described an alarming rate of 
VitDD (<20 ng/mL) among 139 men and women (Elsammak, Al-Wosaibi, Al-Howeish, & Alsaeed, 
2010). Thus, individuals at higher risk of VitDD are those with inadequate VitD3 synthesis from 
reduced sunlight exposure and limited consumption and/or assimilation together with increased 





lactating. The latter group is especially at a higher risk as a result of religious and cultural practices, 
in which women in Saudi Arabia wear long dresses covering most of their skin. 
In Saudi Arabia, in a study conducted in Jeddah the prevalence of VitDD was reported to 
be as high as 80% among women (n=1,172) using a cut-off serum 25(OH)D3 below 50 nmol/L (20 
ng/mL) for VitDD in both rural and urban settings, and across all socio-economic and geographic 
strata. The blood samples were analyzed by a direct competitive chemiluminescence immunoassay 
(CLIA) for quantitative determination of total 25(OH)D3 in serum (LIASON autoanalyzer) 
(Ardawi, Qari, Rouzi, Maimani, & Raddadi, 2011). In another large study (n=12,575) aimed at 
identifying the health risk behaviors and health status of adolescents in Saudi Arabia, VitDD was 
prevalent in 95% of the schools participating in the study using the cut-off serum of 50 nmol/L 
25(OH)D3. The blood samples were analyzed by using immunoassay analyzer Architect 2000 
(Abbott, IL) (AlBuhairan et al., 2015).  
 
Opportunity 
Food fortification of staples is one of the most effective strategies to deliver and maintain 
adequate nutrition to the population at large, especially to those at-risk groups (Allen, de Benoist, 
Dary, & Hurrel 2006). In Saudi Arabia, vitamin D (VitD3) deficiency and insufficiency are prevalent, 
especially among women and young children (N. A. Al Jurayyan et al., 2012; AlBuhairan et al., 
2015; Ardawi et al., 2011b). To address these nutrient gaps, several food products are fortified with 
micronutrients such as iron, niacin, folic acid, vitamin A and VitD3. Although available products 
could provide excellent nutrition to populations, many products do not address the physiological 
status of individuals, their cultural habits, and socio-economic conditions. Moreover, most food 





due to lactose intolerance and other preferences. Thus, new technologies should overcome the 
shortcomings of current products and thus improve the diversity of offerings via food vehicles that 
could prove useful to improve VitD3 status among populations.  
Delivering adequate nutrition to specific groups and facilitating functional food access to a 
larger audience has become a new priority for the food industry (Sloan & Hutt, 2012). Addition of 
bioactives and nutrients, however, is not a straightforward process. Bringing new ingredients into a 
food recipe often leads to food deterioration and rapid spoilage, changes in rheology, modifications 
in sensory attributes, changes in consumption habits and preparation, and interactions with other 
food ingredients; thereby reducing the intended beneficial effect. The technical feasibility of the 
chosen product and the fortificant are some of the many factors that determine the success of the 
fortification process, which includes the level of fortification, the consumption pattern, the 
interactions among nutrients, the stability of premixes, and the physicochemical changes that 
could affect final product’s quality (Allen et al., 2006). 
Among current technologies to address the addition of molecules into food systems, 
encapsulation has become a suitable technology for the delivery of many forms of bioactives and 
flavors. The benefits of encapsulation via micro- or nano-particles made of synthetic or naturally 
occurring molecules (e.g., protein, carbohydrates, and fats) include protection of sensitive 
components and their function, and facilitating the targeted release of molecules (Mahmoud, Amin, 
Salama, & Seliem, 2015). A variety of methods for encapsulation have been demonstrated, requiring 
additional energy input and with varying degrees of success. One of the key factors is that 
encapsulation strategies must vary due to both, the system of dispersal and the bioactive component 
itself. Although there have been very creative strategies for the protection and delivery of bioactive 





the efficacy of the nutritional intervention. It has been proposed that nanotechnology applied to 
encapsulation can solve some of these problems, yielding increased benefits to the public at large 
(Chen, Remondetto, & Subirade, 2006; Sozer & Kokini, 2009). 
 
Vitamin D in Dietary Supplements and Fortified Foods 
VitD in dietary supplements is commonly taken either individually or in combination 
with other micronutrients by people to maintain or improve skeletal health. VitD in supplements 
and fortified foods is available in two forms cholecalciferol and ergocalciferol that are 
chemically different in their side-chain structure. VitD3 is formed by the irradiation of 7-
dehydrocholesterol from the chemical conversion of cholesterol and lanolin, and VitD2 is 
produced by the UV irradiation of ergosterol in yeast (Holick et al., 2011). These two chemical 
forms will be activated to 25(OH)D3 and then to 1,25(OH)2D3. Both have been considered as 
equivalent based on their ability to heal rickets. The metabolism and actions of VitD3  and VitD2 
are identical in many steps (Bikle, 2014). 
VitD3 fortification in the Saudi Arabia market varies from one brand to another and from 
a product to another. Sadat-Ali et al., (2013) have surveyed the Saudi market investigating the 
actual content of the VitD3 fortified in food and compared it to the US Code of Federal 
Regulations. The content of VitD3 varied from 40 IU/L to 400 IU/L in the evaluated products. 
Some fresh milk and yogurt are not fortified with VitD3. All powered milk brands were 
evaluated in this study were fortified with VitD3 in a range of 65.5 - 350 IU/g. In a comparison 
of the VitD3 content in the food items sold in the US market as shown in Table 2.1, it is clear 
that the food items fortified with VitD3 are lower than the recommended dose in US market 





Countries around the world are different in each other in the fortification policy and 
experience. Saudi Arabia has only one mandatory policy for VitD3 fortification: enriched wheat 
and enriched treated flour with 55.1 IU/100 g which is lower than VitD3 fortification in Finland 
(80 IU/L) and the US (62.5 IU/L). Sadat-Ali and his colleagues concluded that food items 
investigated either contain less amount of VitD3 or not fortified. In another study, Alvi, El 
Tabache, Al-Ashwall, & Hammami, (2016) studied the amount of VitD3 levels in fortified low-
fat milk in the Saudi Arabia market and compared it to the nutrition label claims on the products. 
They found that 15% of the products (5 brands) that examined, had less than what label claims. 
The most micronutrients used to fortify common foods, such as milk, bread, or cereal products 
are vitamins A, D, and E. Table 2.2 shows examples of foods fortified with fat-soluble vitamins. 
 
Encapsulation  
A variety of methods for encapsulation have been demonstrated, requiring additional 
energy input and with varying degrees of success. One of the key factors is that encapsulation 
strategies must vary due to both, the system of dispersal and the bioactive component itself. 
Although there have been very creative strategies for the protection and delivery of bioactive 
food components, still there are many questions regarding the impact of these delivery systems 
on the efficacy of the nutritional intervention. It has been proposed that nanotechnology applied 
to encapsulation can solve some of these problems, yielding increased benefits to the public at 
large (Chen et al., 2006; Sozer & Kokini, 2009). 
Nanotechnology is defined as the science, technology, and engineering that allows the 





advantages over other encapsulation techniques. The dispersion containing nanoparticles show 
higher transparency or slight turbidity due to the small particle size. The reduction of particle size in 
the nano-range also affects the stability of emulsions against aggregation and gravitational separation 
as compared to microemulsion systems (Tadros, Izquierdo, Esquena, & Solans, 2004; Wooster, 
Golding, & Sanguansri, 2008). Also, nanoparticles as compared to microparticles and hydrogels 
provide improved bioavailability of bioactive components, especially lipid-soluble substances, such 
as vitamins A, D, E and K, omega-3 fatty acids, carotenoids, and phytosterols (Acosta, 2009; L. 
Chen et al., 2006). 
Adequate emulsification is important for the dispersion of lipid soluble ingredients in food 
systems. Many proteins are used as emulsifiers which they are surface-active molecules that 
improve the stability, promote the formation, and produce oil-in-water emulsions with good 
physicochemical properties (Norde, 2003). The protein of freshly formed oil droplets produced by 
the homogenization of oil-in-water protein mixes will adsorb to the surfaces of it. Therefore, it will 
facilitate further droplet disruption by delaying droplet coalescence and reducing the interfacial 
tension by creating protective membranes around the droplets (Walstra, 2003). Plant proteins, 
especially legume proteins (e.g., pea, soy, chickpea), offer several advantages to forming 
nanoemulsions amenable to disperse lipid-soluble substances such as high stability, improved 
hydrophobicity, low cost, and recognized safety (L. Chen et al., 2006). Food proteins are generally 
recognized as safe substances (Chen et al., 2006; MaHam et al., 2009). Currently, there are several 
methods requiring high or low energy input to disperse lipid-soluble compounds in foods (Table 
2.3), most of which require additional chemical stabilizers. Stabilizing nanoemulsions requires 
additional food grade chemical surfactants, which raises potential toxicological concerns regarding 





Table 2.3 summarizes some different methods to create nanoparticles/emulsions for lipid-
soluble vitamins. The emulsion technology uses are more common in aqueous solutions, and 
nanoemulsions are produced in this medium with droplet sizes ranging between 50 and 1000 nm 
(Sanguansri & Augustin, 2006). Table 2.4 describes the advantages and disadvantages of these 
selected particle reduction methods (Yukuyama, Ghisleni, Pinto, & Bou-Chacra, 2016). 
Pezeshki et al., (2014) prepared vitamin A palmitate-loaded nanostructured lipid carrier 
structures via the hot homogenization procedure. Octyl octanoate was applied as the liquid phase, 
precoil as the solid lipid, and poloxamer as the surfactant. The encapsulation efficiency was about 
98.5%, and the lowest particle size was obtained in the presence of 6% poloxamer. Hategekimana 
et al., (2015) used octenyl succinic anhydride starches as the external phase to design vitamin E 
loaded nanocapsules. The emulsification properties improved by the high level of replacement, 
low interfacial tension, and low molecular weight presented the excellent results and created stable 
nanocapsules. Campani et al., (2016) prepared nanoemulsions contained vitamin K1 for topical 
purposes using spontaneous emulsification method to form the nanoemulsions, which showed a 
desirable quality to be used in commercial spray formulations for the topical absorption of vitamin 
K1. In previous studies, the combination of pH shifting and ultrasound was useful to enhance the 
solubility and surface hydrophobicity of soy protein isolate (SPI), resulting in SPI-based 
nanoparticles with superior emulsifying capacity and stability in the dispersion of VitD3 (H. Lee 
et al., 2016a). 
High-intensity ultrasound treatment is perceived as a safe, non-toxic, and environmentally 
friendly processing method compared to microwave, gamma radiation and electric pulse field 
(Feng, Barbosa-Cánovas & Weiss, 2011). US treatment causes physical-chemical changes such as 





pressure and temperature when applying mechanical waves above the human hearing threshold 
(Jambrak, Lelas, Mason, Krešić, & Badanjak, 2009). Nanoemulsions as delivery vehicles have 
been shown to be one of the best platforms to enhance the biological efficacies and oral 
bioavailability of several phytochemicals (Yu, Huang, & Ru, 2010). There are some 
physicochemical advantages associated with dietary nanoemulsions such as high optical clarity, 
minor aggregation, and more stability (McClements, 2010; McClements & Rao, 2011). These 
nanoemulsions could enhance the encapsulation of liposoluble bioactives and thus become a 
feasible alternative for dietary supplements. 
 
The Absorption of Encapsulated Vitamin D3 
The term bioavailability is defined as the fraction of consumed substances that ultimately 
ends up in the bloodstream (Versantvoort, Kamp, & Rompelberg, 2004). The overall 
bioavailability (F) of a lipophilic substance that has poor water-solubility depends on some 
physiological and physicochemical factors: 
F = FA × FB × FM 
in which, FA is the fraction of the released substance that is absorbed across the intestinal 
epithelia, FB is the fraction of the lipophilic substance released from the delivery system into the 
lumen of the GI tract to become bioaccessible, and FM is the fraction of the absorbed substance 
that arrives the systemic circulation without being metabolized (Versantvoort et al., 2004). 
The bioavailability of substances in the nano-range in humans (Figure 2.1) follows 
features similar to the absorption of bioactive substances and nutrients. After the food or 





dissolution process in the stomach under acidic conditions (pH~1 to 2), which could last 1 to 3 
hours. During this period, pepsin breaks down some of the ingested protein. Dissolution of the 
nanoemulsions in the stomach may or may not occur depending on the stability of the active 
substances in the acidic pH. If the nanoemulsions need protection against the acidic conditions of 
the stomach, they can be microencapsulated using enteric coatings (K. E. Lee, Cho, Lee, & 
Jeong, 2003). As the digested nutrients enter the duodenum, it combines with the bile salts 
released by the gall bladder and pancreatic enzymes. These bile salts emulsify the fats and other 
hydrophobic nutrients. The absorption of nanoemulsion droplets may occur in two types of cells: 
M-cells and epithelium cells. M-cells are assumed to be more effective at absorbing 
nanoparticles, but they are less than 1% of the total intestine area than epithelium cells. The M-
cells are efficient for absorbing various kinds of antigens such as microorganisms, 
macromolecules, and several types of particles, which are then passed to the lymphoid system to 
stimulate immune responses. The epithelial cells, on the other hand, are the most abundant cell 
type lining the gastrointestinal tract, but they are not considered to be effective in absorbing large 
particles (des Rieux, Fievez, Garinot, Schneider, & Préat, 2006). Currently, there are limited 
experimental data on the primary absorption of nanoemulsion particles through epithelium cells, 
and more work is certainly required. The physicochemical characteristics of nanoemulsion 
droplets might be changed as they move through the gastrointestinal tract (e.g., composition, 
aggregation state, size, and charge), and these variables must be taken in consideration when 
investigating the nanoparticles absorption mechanisms (McClements & Rao, 2011).  
During the digestion process, the nutrient or bioactive of interest will be released and 
start its incorporation into micelles (Figure 2.1). This process is known to be facilitated by the 





via facilitated diffusion. There, the mixed micelles reassemble into chylomicrons to transport the 
bioactive compounds to the blood circulation within the lymphatic system (Öztürk, 2017). Thus, 
the loss of biological activity of the metabolized bioactive compound inside the liver is reduced, 
and eventually, bioavailability is improved (Acosta, 2009). 
The fat-soluble vitamins follow the same fate in the upper gastrointestinal tract. During 
digestion, VitD is emulsified into lipid droplets in the stomach and duodenum by the dissolution 
of VitD in the lipid-phase of the food. It has been reported that the free form of VitD is thought 
to be absorbed by the intestinal cells and appeared in the lymph as both esterified and free VitD 
(Reboul, 2015). VitD is incorporated into chylomicrons inside the intestinal wall and reach the 
systemic circulation through the lymphatics. However, a fraction of recently absorbed VitD is 
transferred with carbohydrates and amino acids into the portal system to enter the liver directly 
(IOM 2011). The transport of VitD across the enterocyte requires proteins. VitD is taken up from 
mixed micelles by apical membrane transporters: NPC1L1, SR-BI, and CD36. VitD is either 
transported to the chylomicron incorporation site or enters the cell by passive diffusion. The 
intracellular transport of VitD may include binding proteins, but these binding proteins are still 
unidentified. The free VitD is secreted in the lymph into chylomicrons (apolipoprotein B-
dependent route), although other secretion pathways such as a non-apolipoprotein B-dependent 









Tables and Figure 
Table 2.1: VitD3 content of different products from the US market (followed the US fortification 
guidelines compared to products in Saudi Arabia Market. Adaptive from (Sadat-Ali et al., 2013). 
 
* US FDA. Direct food substances affirmed as generally recognized as safe 
   (Woodhouse, Bs, & Facp, 1981). 











Product Saudi Arabia Market US Market 
(Fortification Level)* 
Fresh Milk 0 – 400 IU/L 400 IU/quarter 
Yogurt 0 – 400 IU/L 40 – 80 IU/RACC** 
Powdered Milk 65.6 – 350 IU/100 g 400 IU/quarter (reconstituted) 
Orange Juice 0 400 IU/quarter 
Cereals 0 40 – 140 IU/serving 





Table 2.2: Examples of foods fortified with fat-soluble vitamins. Adaptive from (Öztürk, 2017b). 
Vitamin Concentration Food Matrix Formulation Outcomes Reference 




vitamin A liver 
store in 
children 
(Dary & Mora, 
2002) 














Vitamin D 10 µg/100 g 
food 
Rye and wheat 
bread 








(Natri et al., 
2006) 
Vitamin D 1000 IU/240 
mL 
10.4 µg/100 g 
food 
10 µg/100 g 
food 





et al., 2003) 




(Daly, Bass, & 
Nowson, 
2006) 
Vitamin D 5 µg/100 g 
food 

















Table 2.2: (cont.): Examples of foods fortified with fat-soluble vitamins. Adaptive from (Öztürk, 2017b). 
Vitamin Concentration Food Matrix Formulation Outcomes Reference 
Vitamin D 100 and 250 
IU/serving size 












Stable VitD in 
the storage and 
process of the 
product 































et al., 2014) 























Table 2.3: Examples of methods used to create nanoparticles/emulsions for lipid-soluble vitamins. 




To design a stable 
nanostructured lipid carrier 






E Emulsion phase 
inversion 
To design stable nanoemulsions 




et al., 2015 
K Spontaneous 
emulsification 
To design an easy and cheap 
preparation of nanoemulsions 





D pH treatment 
and 
ultrasonication 
To design a stable nanoemulsion 
able to encapsulate, disperse,  
and protect VitD3  
Particle size: 70-
116 nm 

















Table 2.4: Advantages and disadvantages of methods produce nanoemulsions. Adaptive from 
(Yukuyama et al., 2016) 
Methods Advantages Disadvantages 
Ultrasound  Less costly than other high-
energy devices 
 More adjustable on surfactant and 
internal structure selection than 
low-energy method 
 Useful only to a lab-scale level 
High-pressure 
homogenization 
 More adjustable on surfactant and 
internal structure selection than 
low-energy method 
 Low process time 
 Expensive 
 Not recommended for thermo- or 
shear-sensitive compounds 
Microfluidization  Controlled size droplets 
 Multiple emulsion preparations 
 Expensive 





 Simple to scale-up 
 No heat-up require 
 Need gradual addition of one phase 
into another 
 Need the presence of liquid crystal 





 Simple to scale-up 
 Limited to the non-ionic surfactants 
 Need LC or ME phases 




 Simple to scale-up 
 Limited amount of oil phase 














Figure 2.1: Schematic of the mechanisms of active ingredient uptake using nanocarriers systems. 
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CHAPTER 3: SOY PROTEIN NANOEMULSIONS IMPROVE STABILITY, 
BIOACCESSIBILITY AND BIOAVAILABILITY OF VITAMIN D3 
ABSTRACT 
BACKGROUND: Deficiency and insufficiency of vitamin D3 (VitD3) afflict populations 
worldwide. Fortification of foods with VitD3 has been present for decades; however, its stability 
in foods is often compromised by its rapid degradation, low absorption, and poor water 
solubility. In this study, soy protein isolate was conditioned using pH shifting and ultrasound 
treatment to create soy protein-based nanoemulsions (SPNEs).  
OBJECTIVE: To examine the ability of soy protein isolates (SPI)-based nanoemulsions to 
improve stability, bioaccessibility, and bioavailability of VitD3 dispersed in SPNEs. 
METHODS: SPNEs were prepared by mixing canola oil (1%, w/w) and soluble SPI (30 
mg/mL) containing VitD3 (150 µg/mL; cholecalciferol) and sonicating (20 kHz) 5 min. SPNEs 
containing VitD3 were compared to controls including VitD3 dispersed in water after sonication 
and in lecithin with canola oil after sonication. SPNEs containing VitD3 were freeze-dried and 
evaluated after resuspension. Particle size was measured using dynamic light scattering 
spectroscopy. VitD3 stability was evaluated after UV-B light exposure for 0, 30, 60 and 120 min 
followed by quantification using and reversed phase HPLC-UV. Bioaccessibility was evaluated 
in a two-compartment in vitro digestion model. Bioavailability was evaluated in adult Long-
Evans hooded rats. Rats were conditioned for a week under an AIN-93M diet before receiving a 
gavage dose of: 1) SPNEs containing VitD3 (2 mL, 150 µg/mL), 2) Oil with VitD3 (0.5 mL, 300 
µg/mL), and 3) Oil without VitD3 (0.6 mL canola oil). After gavage, specific groups of animals 





25(OH)D3 levels in rats were measured post-mortem using a colorimetric (450 nm) sandwich 
ELISA.  
RESULTS: SPNEs containing VitD3 had a particle size of 50-100 nm after freeze-drying. 
Recovery of VitD3 after 60 min UV-B exposure was 52.3%, 12.8%, and 9.8% in SPNEs, 
emulsified in lecithin, or without an emulsifier in water, respectively. VitD3 bioaccessibility was 
higher (P < 0.05) in SPNEs (96%) than emulsified in lecithin (69%), or without an emulsifier in 
water (63%). Pharmacokinetic studies in rats showed that oral delivery of VitD3 in SPNEs 
resulted in an 8.1-fold increase in the AUC (P < 0.05) and reaching a Cmax at 24 hours compared 
to the Oil with VitD3 control.  
CONCLUSIONS: The results revealed that the dispersion of VitD3 in SPNEs protects VitD3 
from UV-B exposure and increases its bioaccessibility and oral bioavailability. Future studies 
will evaluate the sensory properties of SPNEs in food products. 













Vitamin D (VitD) is a fat-soluble vitamin, naturally present in very few foods, added to 
others, and available as a dietary supplement. It is called the sunshine vitamin as it is synthesized 
by humans in the skin after exposure to sunlight. Vitamin D deficiency (VitDD) and insufficiency 
are a recognized public health concern around the world.  Globally, based on a serum 25(OH)D3 
cut-off level of 21 to 29 ng/mL, there might be more than one billion people with VitD3 
insufficiency (Holick, 2007). VitDD can induce growth retardation and skeletal deformities in 
utero and during childhood (rickets) and could exacerbate the risk of bone fractures later in life. 
During adulthood, VitDD can provoke osteopenia and osteoporosis (Al-Daghri et al., 2018). 
Recent evidence has shown the critical role that VitD3 plays in the etiology of chronic diseases, 
including common cancers, diabetes, and autoimmune, cardiovascular and infectious diseases 
(Michael F Holick, 2004). 
In the Middle East, especially in Saudi Arabia, VitDD is highly prevalent, especially 
among women, children and young adults (Al-Daghri et al., 2018; AlBuhairan et al., 2015; Ardawi, 
Qari, Rouzi, Maimani, & Raddadi, 2011). In Saudi Arabia, due to excessive heat, cultural and 
religious practices, populations do not receive adequate sun exposure, and thus, reducing by far 
the largest potential source of VitD (Al-Daghri et al., 2018). Other causes of VitDD include 
reduced consumption of VitD-rich foods and continuous breastfeeding from mothers deficient in 
VitD3 (Al-Daghri et al., 2018). Thus, food fortification technologies that overcome VitD’s poor 
solubility in aqueous matrices while protecting it from environmental woes such as sunlight and 





VitD3 fortification faces many challenges that could hinder the successful delivery of VitD3 
added in foods to the consumers including the use of appropriate emulsifiers, variable oral 
bioavailability, poor water solubility, chemical degradation when exposed to UV light, elevated 
temperature, and / or oxygen (Haham et al., 2012; Tsiaras & Weinstock, 2011). VitD3 
bioavailability is very low due to its extreme hydrophobicity, which leads to low solubility in the 
gastrointestinal tract (GIT) and low chemical stability (Öztürk, 2017b). For that, delivering VitD3 
in the oil-in-water emulsions would enhance its absorption by promoting its solubility and 
incorporation into micelles (Grossmann & Tangpricha, 2015; Ziani, Fang, & McClements, 2012).  
Adequate emulsification is important for the dispersion of lipid soluble ingredients in 
food systems. Many proteins are used as emulsifiers which they are surface-active molecules that 
improve the stability, promote the formation, and produce oil-in-water emulsions with good 
physicochemical properties (Norde, 2003). The protein of freshly formed oil droplets produced 
by the homogenization of oil-in-water protein mixes will adsorb to the surfaces of it. This 
process will facilitate further droplet disruption by delaying droplet coalescence and reducing the 
interfacial tension by creating protective membranes around the oil droplets (Walstra, 2003). 
Plant proteins, especially legume proteins (e.g., pea, soy, chickpea), offer several advantages to 
forming nanoemulsions amenable to disperse lipid-soluble substances such as high stability, 
improved hydrophobicity, low cost, and recognized safety (L. Chen et al., 2006). Food proteins are 
generally recognized as safe substances (Chen et al., 2006; MaHam et al., 2009). Currently, there 
are several methods requiring high or low energy input to disperse lipid-soluble compounds in 
foods (Table 3.1), most of which require additional chemical stabilizers. Stabilizing 
nanoemulsions requires additional food grade chemical surfactants, which raises potential 





Table 3.1 summarizes a few of the different methods to create nanoparticles/emulsions for 
lipid-soluble vitamins or bioactives. The emulsion technology applications are more common in 
aqueous solutions, and nanoemulsions are produced in this medium with droplet sizes ranging 
between 50 and 1,000 nm (Sanguansri & Augustin, 2006). Pezeshki et al., (2014) prepared vitamin 
A palmitate-loaded nanostructured lipid carrier structures via the hot homogenization procedure. 
Octyl octanoate was applied as the liquid phase, precoil as the solid lipid, and poloxamer as the 
surfactant. The encapsulation efficiency was about 98.5%, and the lowest particle size was 
obtained in the presence of 6% poloxamer. Hategekimana et al., (2015) used octenyl succinic 
anhydride starches as the external phase to design vitamin E loaded nanocapsules. The 
emulsification properties improved by the high level of replacement, low interfacial tension, and 
low molecular weight presented, which resulted in stable nanocapsules. Campani et al., (2016) 
prepared nanoemulsions contained vitamin K1 for topical purposes using spontaneous 
emulsification method to form the nanoemulsions, which showed a desirable quality to be used in 
commercial spray formulations for the topical absorption of vitamin K1. In previous studies, the 
combination of pH shifting and ultrasonication was useful to enhance the solubility and surface 
hydrophobicity of soy protein isolate (SPI), resulting in SPI-based nanoparticles with superior 
emulsifying capacity and stability in the dispersion of VitD3 (Lee et al., 2016a). 
The ultrasound treatment is perceived as a safe, non-toxic, and environmentally friendly 
processing method compared to microwave, gamma radiation and electric pulse field (Feng, 
Barbosa-Cánovas & Weiss, 2011). Ultrasound treatment causes physicochemical changes such as 
heating, dynamic agitation, shear stress and turbulence due to cavitation, which generates a high 
pressure and temperature when applying mechanical waves above the human hearing threshold 





platforms to enhance the biological efficacies and oral bioavailability of several phytochemicals 
(Yu et al., 2010). Some physicochemical advantages associated with dietary nanoemulsions 
include high optical clarity, minor aggregation, and more stability (McClements, 2010; 
McClements & Rao, 2011). These nanoemulsions could enhance the encapsulation of liposoluble 
bioactives and thus become a feasible alternative for dietary supplements or ingredients for food 
fortification. 
The present study aimed at determining the ability of soy protein nanoemulsions to improve 
stability, bioaccessibility, and bioavailability of VitD3 dispersed in SPNEs, comparing to oil 
without VitD3, and oil with VitD3 treatments in an animal model. 
 
Materials and Methods 
Nanoemulsions Formulation 
The pH shifting and ultrasonication method is described by Lee et al., (2016). The soy 
protein isolate (SPI, Pro- Fam® 955, 90% on a dry basis) was obtained from Archer Daniels 
Midland (ADM, Decatur, IL, USA). The SPI Pro-Fam 955 is a water-washed intact protein with 
pH 5.0 – 5.5. Canola oil was purchased from a food supplier (Wesson, ConAgra Foods, Omaha, 
NE). A VC-750 ultrasound generator at 20 kHz (Sonics & Materials, Inc., Newtown, CT, USA) 
was used to apply ultrasound treatments. SPNEs were made by adding SPI (3 g) to 100 mL 
deionized water in a 250 mL beaker (3% w/v) and stirred for 30 min at room temperature with a 
magnetic stirrer. The SPI was neutralized to pH 7 with a few drops of 2 M NaOH, and then it 
was adjusted to pH 12 with 2 M NaOH followed by sonication for five minutes. During 





50 oC. Then, samples were stored for 1 hour at room temperature. Samples were neutralized to 
pH 7 with 2 M HCl followed by sonication. Neutralized SPI dispersions were centrifuged (1,200 
× g and 20 oC) for 15 min. VitD3 powder (cholecalciferol) was obtained from Sigma-Aldrich (St. 
Louis, MO, USA¸ ≥ 98% purity) and dissolved in canola oil (8 mg of VitD3 and 1 g canola oil). 
VitD3 powder with an amount of 8 mg was mixed in 1 g canola oil and sonicated for 10 min in 
an ultrasonic bath until VitD3 was completely dissolved in oil. Then, it was added to 100 mL of 
SPI nanoparticle dispersion after stabilization. The contents were thoroughly mixed by vortex for 
10 min. Then, the SPI nanoemulsions (SPNEs) containing VitD3 were treated with 
ultrasonication similar to before as shown in Figure 3.1. The final concentration of VitD3 was 
2.65 µg/mg nanoparticles. 
Lecithin, a commercial emulsifier (Sigma-Aldrich; St. Louis, MO, USA), was used to 
compare against SPNEs. Lecithin was prepared at 10% in ethanol (1 g lecithin in 9 mL ethanol) 
and added at 1 mL into 100 mL solution (99 g DI water, 1 g oil+VitD3) with a final concentration 
of 0.1 mg/g of the solution. The dispersion of VitD3 and lecithin was sonicated in an ultrasonic 
bath for 5 min to incorporate VitD3. A control of VitD3 with no encapsulation was prepared by 
adding 8 mg of VitD3 dispersed in 1 g oil and sonicated in an ultrasonic bath for 5 min. SPNEs 
containing VitD3 were freeze-dried (Labconco Freeze Dryer FreeZone 6 Liter, USA) for four 
days and evaluated after resuspension. 
 
Quantification of vitamin D3 
Samples (i.e., VitD3 without encapsulation, VitD3 emulsified with lecithin, and VitD3 





2, Scientific Industries) and exposed to water-bath sonication (Fisher Scientific, FS 110H) for 5 
min. Later, samples were centrifuged at 14,000 rpm for 10 min at 4° C (Thermo scientific, 
Sorvall ST 16R). Supernatants were filtered (0.22 μm pore size, 15 mm diameter, PTFE syringe 
filter) directly into dram vials (4 mL amber) and injected into reverse phase HPLC for 
quantification of VitD3 (Waters 717 plus Separations Module, Waters, Milford, MA, USA) with 
a C18 column (Phenomenex Luna 3 µm, 150 × 4.5 mm, Phenomenex, Torrance, CA, USA) and 
a photodiode array detector (Waters PDA 996) at 265 nm. The mobile phase was 100% methanol 
at 1 mL/min, and the injection volume was 20 μL. 
For particle size, the number-proportion of nanoemulsions was measured by dynamic light 
scattering (DLS) (NICOMP 380 DLS instrument, Santa Barbara, CA, USA). Samples were diluted 
ten times in distilled water before DLS measurement.  
 
Photochemical stability of vitamin D3 against UV exposure 
Photochemical stability was evaluated using the method adapted from Lee et al., (2016). 
The following freshly prepared samples were evaluated: VitD3 without encapsulation, VitD3 
emulsified with lecithin, and VitD3 emulsified in SPNEs as described before. VitD3 without 
encapsulation was used as a control for VitD3 stability measurements. Samples (5 mL) were placed 
in polystyrene petri dishes (60 mm × 15 mm, Fisher, Pittsburgh, PA, USA) and exposed to 
ultraviolet (UV-B) light at 265.3 nm provided from a transilluminator (Fisher Scientific, 614, 
Pittsburgh, PA, USA). At several exposure time intervals, samples were collected (0.1 mL) at each 
time point (i.e., 15, 30, 60 and 120 min) followed by the addition of methanol (0.9 mL). After that, 





supernatants were filtered with 0.22 mm pore size PTFE syringe filter (13 mm diameter, Whatman, 
Piscataway, NJ, USA) and injected into reverse phase HPLC for VitD3 analysis as described above.  
 
Bioaccessibility 
A two-compartment in vitro digestion model described by Garrett et al. (1999) was used 
to evaluate VitD3 bioaccessibility. Pepsin and pancreatin were obtained from Sigma-Aldrich (St. 
Louis, MO, USA). For the gastric period, 5 mL of the sample was weighed into a 50-mL tube in 
addition to 150 µL canola oil (total oil content = 3% of the sample). After that, 27 mL saline 
were added (0.9% NaCl) in addition to 2 mL porcine pepsin (40 mg/mL in 0.1 M HCl). pH was 
adjusted to 2.0 with a few drops of 1 M HCl. Samples were incubated at 37 oC in an orbital 
shaker at 95 rpm for 1 hour. 
For the intestinal digestion period, pH was adjusted to 5.3 by adding a few drops of 0.9 M 
sodium bicarbonate solution. After that, 9 mL of pancreatin was added, and the contents were 
vortexed. Then, a few drops of 2 M NaOH were added to adjust the pH to 7.5. Finally, samples 
were incubated in an orbital shaker for 2 hrs. After incubation, samples were centrifuged at 3,000 
× g for 20 min at 4° C. 
For the VitD3 determination, 1 mL of the supernatant of micellar fractions was extracted 
in a 10 mL tube. This was conducted without disturbing the lipid layer on top. Methanol (3 mL) 
was added, and the contents were vortexed for 30 s. After that, sample (1 mL) was pipetted into a 
micro-centrifuge tube followed by centrifugation (14,000 rpm, 10 min). A 250 µL of supernatant 
was taken, filtered through a 0.22 µm nylon filter (1 mL syringe) directly into the HPLC vial (4 






Bioavailability was evaluated in adult Long-Evans hooded rats. The protocol (#15118) 
was approved by the Institutional Animal Care and Use Committee of the University of Illinois 
at Urbana-Champaign (Appendix A). 114 rats (male) were purchased from (Charles River 
Laboratories Inc., USA), and housed (2 animals per cage) in Madigan Lab at the University of 
Illinois at Urbana-Champaign. Rats were randomized based on weight in grams (279.22 ± 17.9) 
and conditioned for a week under an AIN-93M diet containing 1,000 IU of VitD3 (Reeves, 
Nielsen, & Fahey, 1993). After a week, animals received a gavage dose of:  
1) VitD3 in SPNEs (SPNE+VitD3; 2 mL, 150 µg/mL),  
2) Canola oil with VitD3 (Oil+VitD3; 0.5 mL, 300 µg/mL), and  
3) Canola oil without VitD3 (Oil-control; 0.5 mL).  
After gavage, animals were euthanized at 0, 1, 9, 24, and 48 hours after oral dose. Serum 
25(OH)D3 levels were measured using sandwich ELISA provided by BioVendor (Asheville, NC, 
USA) and SpectraMax M2e (Molecular Devices, LLC, USA) at 450 nm. The area under the 
curve was calculated using the trapezoidal rule. 
 
Statistical analyses  
For all experiments, SAS software was used for the statistical analysis version 8E (SAS 
Institute, Cary, NC, USA). Tukey's HSD (Honest Significant Difference) was used to determine 






Results and Discussion 
Stability of Vitamin D3 against UV Exposure 
VitD3 in SPNEs treatment had a particle size of 50-100 nm after freeze-drying. The 
reduction of particle size in the emulsion-based delivery system may be useful for some food 
applications to improve the oral bioavailability, greater optical clarity, and higher stability to 
gravitational separation, and droplet aggregation (Guttoff, Saberi, & Mcclements, 2015). Similar 
particles sizes were obtained in previous studies with SPI (Lee et al., 2016b) and pea protein 
isolate (Jiang et al., 2017). 
The instability of VitD3 against broadband light is one of the main technical difficulties 
for its addition in fortified food products, e.g., milk and juices (Ballard, Zhu, Nelson, & Seburg, 
2007). VitD3 dispersed in SPNEs was less susceptible to UV-B photo-oxidation than in lecithin-
based and non-emulsifier control. As shown in Figure 3.2, VitD3 without an emulsifier is labile 
against UV-B light and experienced photochemical degradation very fast. Only 9.8% of VitD3 
remained after 60 min of UV-B exposure. Lecithin helps disperse VitD3 but does not 
encapsulate. Thus, VitD3 emulsified with lecithin showed a similar pace of degradation as the 
control, retaining 12.8% of VitD3 after 120 minutes of UV-B exposure. In contrast, VitD3 
emulsified in SPNEs showed a very slow degradation rate at first and exhibited protective effects 
for VitD3 against UV-B exposure with a recovery of 52.3% after 60 min, but a reduced 
concentration similar to the other treatments by 120 minutes. 
Previous studies have incorporated VitD3 in different carriers, from proteins to 
carbohydrates or their combination. In a similar study, Lee et al., (2016) studied the 





that ~ 90% of VitD3 was retained after 60 min. The difference in degradation rate between 
studies is partially explained by the amount of oil emulsified in soy nanoparticles. In Lee’s study, 
the final amount of oil was 0.25% (w/w) which is four times different than in this study (i.e., 1%, 
w/w). Also, in Lee et al. study, the amount of VitD3 was higher than in this study (i.e., 80 µg/mL 
vs. 100 µg/mL). 
Several authors have shown protective effects of encapsulation of VitD3 against UV light. 
Luo et al. (2012) encapsulated VitD3 in zein nanoparticles coated with carboxymethyl chitosan 
resulting in spherical structures with a particle size from 86 to 200 nm. These authors reported a 
high recovery of VitD3 (70-85%) after exposure to UV-A light (352 nm) (Luo, Teng, & Wang, 
2012). Semo et al. (2007) encapsulated VitD3 in casein micelles (30-530 nm) and demonstrated 
85% recovery after exposure to UV-C at 254 nm (Semo, Kesselman, Danino, & Livney, 2007). 
VitD3 photooxidation was reported to be 1,4- cycloaddition reaction initiated by light absorption 
by sensitizers and an ene-type reaction with singlet oxygen (Li & David, 1998; Yamada, 
Nakayama, Takayama, Itai, & Iitaka, 1983). Hence, the degradation rate of VitD3  due to 
oxidation reaction will be reduced due to a decrease on the UV-B light absorption given by the 
micro- or nanoparticles wall, which finally results in the stability of VitD3 (H. Lee et al., 2016a). 
Addition of oil might potentiate the oxidation, so the dispersion of VitD3 in nanoemulsions might 
show lower protection than encapsulation without oil (Öztürk, 2017). 
 
Bioaccessibility of vitamin D3 from several dispersions 
The concentration of bioaccessible VitD3 was measured after a two-compartment in vitro 





(HPLC) analysis. The bioaccessibility of VitD3 in the SPNEs containing VitD3 was 32.73% higher 
(P < 0.01) than the control (VitD3 in canola oil) and 14.08% higher (P > 0.05) than VitD3 dispersed 
with lecithin in water (Figure 3.3). This suggests that the bioaccessibility of VitD3 is dependent 
on the type of the carrier, indicating that dispersion in SPNEs is a superior vehicle for delivery 
VitD3.  
Several studies have shown that the reduction of the particle size into the nano-range 
resulted in a significant increase in the bioaccessibility of lipophilic substances such as carotenoids 
(Zhang et al., 2017) and curcumin (Laura Salvia-Trujillo, Martín-Belloso, & McClements, 2016). 
In similar study but with a different surfactant, Lin et al., (2016)  demonstrated that the 
encapsulation of VitD3 in corn protein hydrolysate, with a particle size ranging between 102 and 
121 nm, increased the bioaccessibility of VitD3 up to 85% compared to the free VitD3 after an in 
vitro digestion method, which was different from the one used in this work described in F. Chen, 
Li, & Tang, (2015). Qian, Decker, Xiao, & McClements, (2012) studied the influence of carrier 
oil based nanoemulsions stabilized with Tween 20 on -carotene bioaccessibility. The 
bioaccessibile amount of -carotene encapsulated in this system was around 66%, with particle 
size on average 210 nm. Also, Mayer, Weiss, & McClements, (2013) reported a high 
bioaccessibility (> 95%) of vitamin E nanoemulsions stabilized with Tween 80 with a particles 
size averaging 40 nm. These findings suggest that the stabilization and nanoemulsification or 








Vitamin D3 Bioavailability 
We examined the bioavailability of VitD3 using an animal model with adult male rats. 
Rats are a good model to evaluate the bioavailability of vitamins and minerals because of its high 
response to vitamins and minerals deficiencies (Baker, 2008). The total serum concentration of 
25(OH)D3 after oral administration of VitD3 in SPNEs was 3.42 ± 1.01 ng/mL at 24 hours, 
which was higher than the Oil+ VitD3 control (1.36 ± 0.26 ng/mL) or the oil without VitD3 
treatment (0.41 ± 0.244 ng/mL) (Figure 3.4). Pharmacokinetic results showed that oral delivery 
of VitD3 in SPNEs resulted in an 8.1-fold increase in the area under the curve (AUC) 124.46 
µg/mL h (P < 0.05) and reaching a Cmax at 24 hours compared to the Oil+VitD3 control. Oral 
delivery of Oil+VitD3 treatment resulted in a 4.79-fold increase in the AUC, and statistical 
different (P < 0.05) compared to the other groups.  
The most accurate biomarker to test VitD3 status is measuring serum 25(OH)D3 (zerwekh 
JE, 2008). In a similar study with a different surfactant, Kadappan et al., (2018) evaluated the 
bioavailability of nanoemulsions-based delivery of VitD3 in mice and demonstrated that quillaja 
saponin-nanoemulsions containing VitD3 (40 nm) increased the serum concentration of 
25(OH)D3 by 73.10% (13.1 ± 0.09 vs. 22.7 ± 1.10 ng/mL, P < 0.01) showing that the reduction 
of the particle size improves the bioavailability of VitD3. Moreover, Lee et al. (2011) showed 
that the oral delivery of nanoemulsions of a vitamin mixture (vitamins A, D, and E) in rats 
increased the plasma concentration AUC compared to controls. In this study, the nanoemulsion 
particle size was on average 100 nm, which enhances the absorption of the cargo due to its larger 





Nanoemulsion delivery systems are becoming primary approaches for innovative 
strategies in the treatment and prevention of diseases. Pre-clinical studies in anti-cancer drugs  
such as dacarbazine and tamoxifen, and in anti-inflammatory drugs such as aspirin, have shown 
an increased efficacy and bioavailability of nano-formulations (Subramanian et al., 2008; J.-B. 
Tagne, Kakumanu, & Nicolosi, 2008; J. B. Tagne, Kakumanu, Ortiz, Shea, & Nicolosi, 2008). 
Data from other studies have found the same outcomes on the ability of nanoemulsions in 
dispersing and stabilizing fat-soluble vitamins at lower particle size resulting in increased 
absorption. In a pharmacokinetic study in rats, the encapsulation of vitamin E by a modified 
emulsification technique in three different formulations consist of medium chain triglyceride 
(MCT), egg lecithin and oleic acid with different composition were dispersed in an adequate 
alcohol solution (particle size = 87.7 nm) resulted in a 1.6-fold improvement in the plasma AUC 
(Gong et al., 2012). In another study, -tocopherol was loaded in three different formulations of 
nanoemulsions prepared by a mechanochemical method applying a microfluidizer and homo-
mixer. These formulations were formed of water and glycerol as aqueous media, MCT as an oil 
medium, and soybean lecithin and decaglyceryl monooleate as an emulsifier. The bioavailability 
of -tocopherol loaded-nanoemulsions in rats showed higher plasma concentration with a 2.6-
fold improvement in the bioavailability compared to the control mixture of oil and -tocopherol 
(Hatanaka et al., 2010). Therefore, based on our findings and those of others, it is clear that the 
stabilization of VitD3 in nanoemulsions increased the absorption of VitD3. This suggests that 
soy-protein nanoparticles can be used to effectively protect the stability and enhance the 





The present study has some limitations that need to be acknowledged. The studies used 
one concentration of VitD3. Also, the effect of the oil type and its concentration on the particle 
size and the stability of SPNEs need further evaluation. 
 
Conclusions 
The combination of pH shifting followed by ultrasonication is an effective method to 
decrease the particle size of soy protein and oil droplets, facilitating the dispersion of non-polar 
compounds such as VitD3, resulting in stable nanoemulsions. Dispersion and stabilization of 
VitD3 in SPNEs resulted in higher protection against UV photooxidation, higher bioaccessibility, 
and higher bioavailability. Future studies evaluating the incorporation of SPNEs containing 
VitD3 into foods and the bioefficacy of this addition in clinical trials are granted. It will help to 
better address health issues (i.e., micronutrient deficiencies) worldwide as well as to instigate 
interest of stakeholders to further the research in the area of functional SPNEs. 
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Table and Figures 
Table 3.1: Examples of methods used to create nanoparticles/emulsions for lipid-soluble vitamins. 
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nanostructured lipid carrier 






E Emulsion phase 
inversion 
To design a stable 





et al., 2015 
K Spontaneous 
emulsification 
To design an easy and cheap 
preparation of nanoemulsions 





D pH treatment 
and 
ultrasonication 
To design a stable nanoemulsion 
able to disperse, encapsulate, and 
protect VitD3  
Particle size: 
70-116 nm 


































Figure 3.2: VitD3 stability after UV-B exposure. Control: VitD3 dispersed in water (no encapsulation); 
VitD3 emulsified with lecithin; and VitD3 emulsified with SPNEs. Data points represent means ± SD. Points 




















































Figure 3.3: Bioaccessibility of VitD3 after two-compartment simulated in vitro digestion. Bars represent 
















































Figure 3.4: The in vivo bioavailability of VitD3 in rats. Each point represents the average of the serum 
concentration 25(OH)D3 ± SD. Oil-control (n=36) did not receive VitD3 (0.6 mL canola oil); Oil+VitD3 
(n=36) was the positive control and received (0.5 mL, 300 µg/mL), and SPNEs+VitD3 (n=36) received 
VitD3 dispersed in SPNEs (2 mL, 150 µg/mL). Points with different superscripts (a,b,c) represent 
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CHAPTER 4: EVALUATE THE BIOEFFICACY OF SOY PROTEIN 
NANOEMULSIONS CONTAINING VITAMIN D3 TO IMPROVE CIRCULATING 
VITAMIN D3 IN SAUDI ARABIAN POPULATIONS WITH VITAMIN D3 
INSUFFICIENCY AND IDENTIFY POTENTIAL FACTORS ASSOCIATED WITH 
IT: A FEASIBILITY STUDY 
ABSTRACT 
BACKGROUND: Deficiency and insufficiency of vitamin D (VitD3) is a major public health 
problem in Saudi Arabia. Inadequate of VitD3 status has been associated with several chronic 
disease conditions such as diabetes, autoimmune disease, infectious, some types of cancers, and 
cardiovascular disease, most of which are present in Saudi Arabian populations. 
OBJECTIVE: The objective of this pilot, randomized control trial was to describe the effect of 
VitD3 supplementation delivered in soy protein nanoemulsions three times a week for two weeks 
on serum 25(OH)D3 in an adult population with VitD3 insufficiency in Saudi Arabia. Also, to 
identify which lifestyle choices, as well as anthropometric indicators, could adversely impact 
25(OH)D3 serum level. 
METHODS: Soy protein nanoemulsions (SPNEs) were prepared by mixing canola oil (1%, 
w/w) and soluble soy protein isolates (SPIs) (30 mg/mL) containing VitD3 (80 µg/mL; 
cholecalciferol) and sonication (20 kHz) for 5 min. SPNEs-containing VitD3 were dispersed in 
drinkable yogurt. In this clinical trial, a screening of 212 adult volunteers (19-45 years old) was 
completed. During the screening, participants were given a questionnaire addressing their 
frequency of sun exposure, sunscreen use, daily intake of dairy products, and history of VitD3 or 





anthropometric measures (weight and height), sex, age, ethnic background, and medical history. 
From this population, subjects with VitD3 insufficiency between 10 and 40 ng/mL were 
randomized and divided [based on baseline 25(OH)D3 values and sex] into one of three groups: 
placebo, VitD3 control (100 µg, 4,000 IU), and SPNEs-containing VitD3 treatment group (100 
µg, 4,000 IU). All treatments were provided to participants three times a week for two weeks at 
one of the food grade rooms assigned for such experiments. Blood samples were collected from 
the participants at their first visit and then at the end of two weeks. 25(OH)D3 was determined in 
serum by using a certified ELISA test.  
RESULTS: Prevalence of VitD3 insufficiency was 24.6% in males vs. 28.4% in females. After 
two weeks, the placebo group slightly increased the serum 25(OH)D3 levels by 2% (from 29.05 
± 8.82 to 29.66 ± 8.63, P = 0.002). The VitD3 control group increased serum 25(OH)D3 levels by 
15.32% (from 29.88 ± 8.93 to 34.46 ± 7.51, P = 0.001). Whereas, the SPNEs containing VitD3 
increased the serum 25(OH)D3 levels by 50.67% (from 29.43 ± 8.88 to 44.34 ± 7.35, P = 0.001). 
In evaluating the risk estimate of VitD3 insufficiency based on odds ratio (95% CI), subjects 
reporting multivitamin consumption (OR 0.369, 95% CI 0.173-0.787, P = 0.009) were less likely 
to be deficient. 
CONCLUSIONS: Delivery of VitD3 stably dispersed in SPNEs in a food matrix such as yogurt 
resulted in higher improvement of circulating 25(OH)D3 level in adult subjects with VitD3 
insufficiency. This will support the continuous development of a highly effective and stable food 
micronutrient delivery technology as an alternative strategy that can be used to increase VitD3 
status among at-risk populations, especially women and children in Middle Eastern countries. 






Vitamin D (VitD3 or cholecalciferol) is an essential fat-soluble vitamin required in 
promoting bone health, regulating blood calcium levels, and its deficiency related to many 
diseases and conditions such as autoimmune, cancer, diabetes mellitus, hypertension and 
infectious diseases (Holick & Chen, 2008). VitD3 has been associated with the function of organs 
and pathogenesis of several disease conditions such as muscle physiology  (Boland, 1986), certain 
cancers (Grant, 2018), diabetes (Altieri et al., 2017), multiple sclerosis (Summerday et al., 2012), 
and cardiovascular disease (Al Mheid & Quyyumi, 2017), among others. Cholecalciferol or VitD3 
is formed in the skin from 7-dehydrocholesterol, but also could be synthesized through UV 
irradiation of lanolin. Ergocalciferol or VitD2 is obtained by UV irradiation of ergosterol from the 
yeast. In liver, VitD3 metabolized to its circulating form, 25(OH)D3, by the enzyme VitD-25-
hydroxylase. Its hormonal or active form occurs in the kidney, where the circulating form is 
activated to 1, 25(OH)2D by the enzyme 25(OH)D-1-hydroxylase. There are many factors 
regulating VitD3 activation, the most important are Ca, P, and PTH levels (Tsiaras & Weinstock, 
2011).  
The definition of sufficient, insufficient, and deficient serum levels of VitD3 is different 
depending on the country. Vitamin D deficiency (VitDD) is defined at a cut-off of 20 ng/mL in 
serum (multiply by 2.5 to convert to nmol/L). Although under debate, the VitD3 insufficiency 
range is recognized from 21-29 ng/mL (Holick et al., 2011). The normal range of VitD3 varies 
from 30-100 ng/mL, with a preferred range between 30-60 ng/mL (Holick, 2007). The US Institute 
of Medicine (IOM 2011) defines deficiency at a serum level of 25(OH)D3 below 12 ng/mL and 
insufficiency at a serum level between 12–20 ng/mL. In Saudi Arabia, scientists have invariably 





for example, was reported at circulating 25(OH)D3 of less than 39 ng/mL (Elsammak et al., 
2011), less than 30 ng/mL  (Abdelkarem et al., 2016; Al-Elq, 2012; Al-Mogbel, 2012; Al-Turki 
et al., 2008; Ali et al., 2012; Alsuwaida et al., 2013; Ardawi et al., 2011a) and less than 20 
ng/mL (Al-Daghri, Al-Saleh, et al., 2015; Al-Daghri, Aljohani, et al., 2015). This discrepancy in 
the cut-off used accounts for the different and seemingly high rates of VitDD and insufficiency 
reported from Middle Eastern countries.   
With the advent of improved food fortification technologies, the prevalence of rickets in the 
western hemisphere has been virtually eradicated. This has not been the case for the Middle East 
region. Although sunlight exposure (i.e., UV-B irradiation) results in plenty of VitD3 synthesis 
throughout the year and that adequate sunlight is available in Middle Eastern countries (located 
within longitudes 20o and 40o N), recent reports describe some of the highest rates of rickets in the 
world (Prentice, 2013). Although large prospective population-based studies are limited, some 
inferences could be obtained from a few cross-sectional and clinical trials.  
In a small retrospective study, Al-Jurayyan et al., (2012) found that from January 1990 to 
December 2009 the prevalence of rickets was 68% among 85 Saudi children and adolescences (2-
18 y) living Riyadh. This was in large extent explained by the reduced sunlight exposure, cultural 
practices, skin coloration, and limited calcium intake. In another cohort study, Erfan et al., (1997) 
found that maternal VitDD was strongly associated with rickets in infants. Moreover, lack of sunlight 
exposure and exclusive breastfeeding (i.e., from VitDD lactating mothers) were the underlining 
causes of VitDD among a cohort of 61 infants in Riyadh (Al-Mustafa et al., 2007). Rickets was 
associated with both limited sunlight exposure and low dietary calcium in two other studies with 
children and adolescents (Abdullah et al., 2002; Al-Jurayyan et al., 2012). A recent report from a 





and women (Elsammak, Al-Wosaibi, Al-Howeish, & Alsaeed 2010). Thus, individuals at higher risk 
of VitDD are those with inadequate VitD3 synthesis from reduced sunlight exposure and limited 
consumption and/or assimilation together with increased VitD3 demand. This includes children, 
adolescents, and women of reproductive age, pregnant and lactating. The latter group is especially 
at a higher risk as a result of religious and cultural practices, in which women in Saudi Arabia wear 
long dresses covering most of their skin.  
Adequate and supportive fortification technologies to address VitDD face many 
challenges in Saudi Arabia. Successful delivery of VitD3 via the food supply could be limited 
due to variable oral bioavailability, low water solubility, chemical degradation when exposed to 
light, oxygen, and elevated temperature (Haham et al., 2012; Tsiaras & Weinstock, 2011). VitD3 
bioavailability is very low due to low chemical stability (Öztürk, 2017b), and its extreme 
hydrophobicity which leads to low solubility in the gastrointestinal tract. For these reasons, the 
dispersion of VitD3 in oil-in-water emulsions could enhance its bioaccessibility by promoting its 
solubility, incorporation, and stability within micelles (Grossmann & Tangpricha, 2015; Ziani et 
al., 2012). 
Nanotechnology has become a valuable application in the biomedical field, and 
nanocarrier formulations have proved useful for many clinical therapies in cancer chemotherapy 
(Nishiyama, 2007). Nanoemulsion-based delivery vehicles have been shown to be one of the best 
platforms to enhance the oral bioavailability and biological efficacies of several phytochemicals 
such as anthocyanins, curcumin, and flavonoids (Yu et al., 2010). There are some 
physicochemical advantages associated with dietary nanoparticles, such as higher stability, high 
optical clarity, and minimal aggregation (McClements, 2010; McClements & Rao, 2011). The 





potential development of new products, new functional materials, novel processing technologies, 
and design of nanosensors for food biosecurity and safety (Moraru, Huang, Takhistov, Dogan, & 
Kokini, 2009).  
The dispersion of fat-soluble ingredients in food systems depends on the solubility and 
the particle size. Several proteins are surface-active molecules suitable to be used as emulsifiers 
because they promote the formation, stability, and creation of oil-in-water emulsions with 
desirable physicochemical properties (Norde, 2003). These proteins produced by the 
homogenization of oil-in-water protein mixes will adsorb to the surfaces of the oil droplets. For 
that, it will decrease the interfacial tension by forming protective membranes around the droplets 
and promote further droplet disruption by delaying droplet coalescence (Walstra, 2003). Plant 
proteins (e.g., chickpea, soy, pea), are generally recognized as safe substances, which offer many 
advantages for the creation of nanoemulsions amenable to disperse fat-soluble substances 
including improved hydrophobicity, high stability, recognized safety, and low cost (L. Chen et al., 
2006). The use of food-based proteins is very appealing to the food industry due to the current 
consumer perception on the use of nanoparticles in foods, their mobility routes from food to the 
person to the environment and back to the person, as well as their potential independent effect on 
health (Jain, Ranjan, Dasgupta, & Ramalingam, 2018).  
High-intensity ultrasound (US) technology is perceived as a safe, non-toxic, and 
environmentally friendly processing method compared to gamma radiation, electric pulse field, 
and microwave (Feng, Barbosa-Cánovas & Weiss 2011). In previous studies, the combination of 
pH shifting and ultrasonication was helpful to develop soy protein isolate (SPI) nanoparticles 
with enhanced surface hydrophobicity and solubility. These particles were amenable for the 





enhance the encapsulation of liposoluble bioactives and thus become a possible alternative 
delivery system. 
In this study, the author evaluated the effect of oral delivery of VitD3 stably dispersed in soy 
protein nanoparticles created from ultrasound and pH shifting on 25(OH)D3 status after two-week 
treatment among adults with VitD3 insufficiency under a randomized controlled trial. The author 
hypothesized that repeated doses of a drinkable yogurt supplemented with SPNEs containing VitD3 
would increase serum circulating 25(OH)D3. Also, the author explored other potential associated 
outcomes with VitD3 status such as milk consumption, sun exposure duration, multivitamin 
supplement consumption, vitamin D supplement consumption, food rich in VitD consumption, BMI, 
and percent body fat. To our knowledge, this study is the first to assess the bioefficacy of SPNEs 
containing VitD3 on the circulating serum 25(OH)D3 concentrations levels. 
 
Methods and Materials  
Soy Protein Nanoemulsion Formulation 
The pH shifting and ultrasonication method was described by Lee et al., (2016). The soy 
protein isolates (SPI, Pro- Fam® 955, 90% on dry basis) were provided from by Archer Daniels 
Midland (ADM, Decatur, IL, USA). The SPI Pro-Fam 955 are water-washed intact protein, and 
its pH is 5.0 – 5.5. Canola oil was purchased from a food supplier (Wesson, ConAgra Foods, 
Omaha, NE). A VC-750 ultrasound generator at 20 kHz (Sonics & Materials, Inc., Newtown, 
CT, USA) was used to create the nanoparticles. Soy protein nanoemulsions (SPNEs) were made 
by adding SPI (3 g) to 100 mL deionized water in a 250 mL beaker (3% w/v) and stirred for 30 
min at room temperature with a magnetic stirrer. The SPI was neutralized to pH 7 with a few 





During sonication, the beaker was placed in an ice bath to control the temperature of the sample 
below 50 oC after 5 min of sonication. After each treatment, samples were stored for 1 hour at 
room temperature. Samples were neutralized to pH 7 with a few drops of 2 M HCl followed by 
centrifugation (1,200 ×g, 20 oC) for 15 min. Food grade VitD3 powder (cholecalciferol) was 
obtained from Sigma-Aldrich (St. Louis, MO, USA¸ ≥ 98% purity) and dissolved in canola oil (8 
mg of VitD3 and 1 g canola oil). VitD3 powder with an amount of 8 mg was mixed in 1 g canola 
oil and sonicated for 10 min in an ultrasonic bath until VitD3 was completely dissolved in oil. 
Then, it was added to 100 mL of SPI nanoparticle dispersion after stabilization. The contents 
were thoroughly mixed by vortex for 10 min. Then, the SPI nanoemulsions (SPNEs) containing 
VitD3 were treated with ultrasonicated similar to before as shown in Figure 4.1. SPNEs 
containing VitD3 were freeze-dried (Labconco Freeze Dryer FreeZone 6 Liter, USA) for four 
days and evaluated for VitD3 content after resuspension. 
 
Subjects 
The Institutional Review Board (IRB) of the College of Applied Medical Sciences at 
King Saud University, Saudi Arabia, and the University of Illinois at Urbana-Champaign, USA, 
approved the research protocol (CAMS 076-3839) and (19013), respectively (Appendix B and 
C). Participants received written, and verbal descriptions of the study signed the consent form 
and received a copy for their records. Between February and April 2017, a total of 212 subjects 
(19-45 years old) were screened. During the screening, serum 25(OH)D3 was determined in 
serum using a certified ELISA test (Fortress Diagnostic Limited, United Kingdom). Participants 
were given a questionnaire with a series of questions designed by Bolek-Berquist et al. (2009) to 





exposure, sunscreen use, daily intake of dairy products, and history of VitD3 or calcium 
supplementation. Also, the following information was collected from participants: 
anthropometric measures (weight and height), sex, age, ethnic background, and medical history 
(Crohn's disease, ulcerative colitis, diarrhea or celiac disease). Height was measured by using 
Universal Wall Mounted Height Rod, and weight was collected using InBody 720 Body 
Composition Analyzer at the Clinical Nutrition Clinic, King Saud University. The cutoff points 
from Gallagher et al., (2000) were adjusted for the percentage of body fat and used to classify the 
person’s body fat status. Values of BFM% were adjusted for age, sex, and race. More than 26% 
and 39%, for males and females, respectively, are considered to indicate obesity. Then, BMI was 
calculated from these parameters after entering the height measurement into InBody 720 Body 
Composition Analyzer. 
 
Product selection and preparation 
One of the most popular drinkable yogurt brands in Saudi Arabia (i.e., Almarai brand) 
was used to disperse the oral treatments used in this clinical trial. The drink is sold in 100 mL 
package and is made from 2% cow’s (Appendix E). Dry SPNE containing VitD3 was mixed 
with this yogurt on the day the patient visited the clinic. The amount of VitD3 in the SPNEs was 
84 IU/mg (2.1 µg/mg). The final dose of VitD3 delivered in 100 mL of yogurt was 4,000 IUs 
(100 µg). SPNEs added to yogurt was accurately weighed (3 decimals) and then added to the 
yogurt and mixed by gently inverting the bottle for 30 seconds. To prepare the positive control 
treatment, an aliquot of VIDROP Liquid supplement (VitD3 for Baby 400 IU/drop; Medical 
Union Pharmaceutical, Egypt) (Appendix F), was accurately measured using an analytical 





sample was mixed by gentle inversion of the bottle for 30 seconds. To prepare each treatment 
dose, samples were made fresh the same day participants arrived at the clinic.  
 
Study design 
The study design is shown in Figure 4.2. From the initial screening, participants were 
excluded from the clinical trial if they had a disease condition that could reduce the absorption of 
VitD3, i.e. (Crohn's disease, ulcerative colitis, diarrhea, and celiac disease), if they were younger 
than 18 years or older than 45 years, and if they had a serum 25(OH)D3 levels below 10 ng/mL and 
above 40 ng/mL. After applying the exclusion criteria, 39 volunteers were randomized based on 
baseline 25(OH)D3 value, sex, age groups, and BMI, as shown in Table 4.1, into one of three 
groups. The placebo group received the drinkable yogurt (100 mL) without VitD3. The positive 
control group received drinkable yogurt (100 mL) containing VitD3 (4,000 IU) from a 
commercial supplement (VIDROP). The VitD3 in SPNEs treatment group received the drinkable 
yogurt (100 mL) with 4,000 IU cholecalciferol mixed in SPNEs. Each participant received a total 
of six doses (yogurt drink), which corresponded to their assigned group within two weeks. 
 
All treatments were provided to participants three times a week (every other day) for two 
weeks at one of the food grade rooms assigned for such experiments in the Clinical Nutrition 
Clinic at King Saud University, Saudi Arabia. This room is a 130 ft2 equipped with a digital 
balance, volumetric tools, and a refrigerator. All participants were assigned a three-digit 
identification code. Participants drank the corresponding dose (kept at 4 – 5°C) within 5 minutes 









At their first visit and then at the end of two weeks, blood samples were collected from 
all participants in the Emergency Clinic in the same building where the Clinical Nutrition Clinic 
is located. Blood samples were let clot at room temperature for 15 minutes, and serum was 
obtained after low-speed centrifugation (1,000 × g) at 4oC. Then, serum samples were stored at 
−80oC until further analysis (i.e., within 2-3 weeks). Serum 25(OH)D3 was measured in serum 
using a certified ELISA test provided by (Fortress Diagnostic Limited, United Kingdom) and 
SpectraMax M2e purchased from (Molecular Devices, LLC, USA).  
 
Statistical analyses 
SPSS statistical software package was used for all data analysis (version 25, SPSS Inc.). 
Kruskal-Wallis and paired t-test were used to determine statistical differences among groups and 
the level of significance was established at P < 0.05. Wilcoxon rank sum test was used for 
continuous variables and Chi-square or Fisher’s exact test for categorical variables to compare 
VitD3 sufficient and insufficient subjects. Also, a multiple logistic regression model was used to 
evaluate the effects of questionnaire responses on odds ratios for VitD3 insufficiency.  
 
Results and Discussion 
Vitamin D3 status among adults 
Two hundred and twelve subjects participated in the screening and completed the 
demographic form (Appendix G) and vitamin D questionnaire (Appendix D). Also, their 
anthropometric measurements were collected (Table 4.2). Over half of the subjects were male 





adults was 54.33 (20.75) ng/mL. Nearly 25.94% had serum 25(OH)D3 levels less than 40 ng/mL 
and 74.05% subjects were VitD3 sufficient (i.e. >40 ng/mL). VitD3 insufficiency was slightly 
more prevalent among women than in men (28.4% vs. 24.6%, P > 0.05).  
Table 4.2 summarizes all the answers to the vitamin D status questionnaire. Subjects 
reporting more than 30 min a day of sun exposure was 38.67%, and the mean  SD of daily milk 
servings was 1.1  0.75. Over half of subjects (67.45%, n=143) ingested a daily multivitamin, 
and only 9.43% (n=20) took VitD supplements. Moreover, 10.84% (n=23) reported a weekly 
consumption of mushroom, 8.96% (n=19) reported a daily use of cod liver oil, 10.37% (n=22) 
reported a weekly consumption of salmon, 34.9% (n=74) reported a weekly consumption of tuna, 
and 76.41% (n=162) reported daily or weekly consumption of eggs. Nine subjects (4.24%) 
reported sun tanning, 20.75% (n=44) reported sunscreen use, and only one subject reported 
tanning booth use in the past year. Over two-thirds of the subjects (71.22%, n=151) were 
overweight or obese with a BMI > 25 kg/m2. Table 4.3 shows the characteristics of subjects with 
and without VitD3 Insufficiency. 
The present results did not match with the high prevalence rates of VitDD in Saudi 
Arabia as reported in other studies (AlBuhairan et al., 2015; Al-Jurayyan, Mohamed, AlIssa, & 
Al-Jurayyan, 2012; Ardawi et al., 2011a). This discrepancy might be due to many reasons 
including the education levels, seasonality, food intake, body weight, and the type of population. 
Our population was from King Saud University campus, where participants’ education level and 
health awareness are higher than other parts of the city.  
In this study, 74 female subjects (28.4%) had serum 25(OH)D3 levels below 40 ng/mL, 





disproportionately affects women and young children in Saudi Arabia. In Saudi Arabia, in a study 
conducted in Jeddah the prevalence of VitDD was reported to be as high as 80% among women 
(n=1,172) using a cut-off serum 25(OH)D3 below 50 nmol/L (20 ng/mL) for VitDD in both rural 
and urban settings, and across all socio-economic and geographic strata. The blood samples were 
analyzed by a direct competitive chemiluminescence immunoassay (CLIA) for quantitative 
determination of total 25(OH)D3 in serum (LIASON autoanalyzer) (Ardawi et al., 2011c). In 
another large study (n=12,575) aimed at identifying the health risk behaviors and health status of 
adolescents in Saudi Arabia, VitDD was prevalent in 95% of the schools participating in the study 
using the cut-off serum of 50 nmol/L 25(OH)D3. The blood samples were analyzed using an 
immunoassay analyzer (Architect 2000, Abbott, IL) (AlBuhairan et al., 2015). VitDD can 
accelerate osteoporosis and osteopenia, cause osteomalacia and muscle weakness, and increase the 
risk of fracture (Holick & Chen, 2008). Moreover, VitDD has been associated with certain cancers 
(Giovannucci et al., 2006), diabetes (Muscogiuri et al., 2012), multiple sclerosis (Brown, 
Allington, Rivey, & Summerday, 2011), and cardiovascular disease (Michos & Melamed, 2008). 
Thus, optimal VitD3 status is of foremost importance to maintain calcium homeostasis. Both 
adequate VitD intake and sunlight exposure are necessary to maintain adequate serum levels of 
VitD3 for optimal function, especially among women. 
It was hypothesized that using a validated VitD status questionnaire could be useful to 
identify some behaviors associated with the likelihood of young adults’ subjects to be at risk of 
VitDD. A multiple logistic regression model was performed to determine the odds ratio for 
VitD3 insufficiency based on individual answers in the vitamin D status questionnaire (Table 
4.4). Results showed that only the subjects who reported the use of multivitamins (OR 0.369, 





measured were not associated with VitD3 insufficiency. It is expected that the consumption of 
supplements containing VitD3 results in higher VitD3 status. Tangpricha, Pearce, Chen, & 
Holick, (2002) reported similar results. In their study, a questionnaire was administered to assess 
the consumption of foods rich and supplemented with VitD3 and blood was drawn to assess 
serum 25(OH)D3 levels among young adults (n=307) aged > 18 years living in the USA. They 
found that higher 25(OH)D3 levels were correlated with the daily intake of multivitamins 
containing at least 400 IU of VitD3. Thus, dietary supplements containing VitD3 could also be 
part of public health recommendations to address VitD3 insufficiency.  
The prevalence of VitDD is greater in morbidly obese patients compared to those with 
normal body weight. In a recent meta-analysis, VitDD among morbidly obese was 35% more 
prevalent than in those subjects with normal BMI. This might be due to a decreased hepatic 
synthesis of 25(OH)D3 as a result of pro-inflammatory cytokines, decreased exposure to sunlight, 
and trapped VitD3 in adipose tissue (Miñambres et al., 2015). In this study, subjects with a BMI 
higher than 25 kg/m2 were as likely to be VitD3 insufficient as those with normal BMI (OR 
1.071, 95% CI 0.539-2.129, P = 0.843). These results were similar to those found by Hayek et 
al., (2018), Arunabh et al., (2003), and Scragg et al., (1995) who worked with adults in Lebanon 
(n=344), in the USA (n=410), and in New Zealand (n=390), respectively. Similarly, in this study, 
there was no association between the percentage of body fat mass and lower 25(OH)D3 levels on 
males and females, (OR 0.651, 95% CI 0.298-1.419, P = 0.280) and (OR 0.392, 95% CI 0.044-
3.467, P = 0.399). Similar to our results, it was reported that a high percentage of body fat mass 
was not associated with low VitD3 status among 163 obese Thai individuals (59.5% female, 
40.5% male) (Chattranukulchai et al., 2015). In another study, Hayek et al., (2018) found a 





It has been hypothesized, that this negative association is observed among obese individuals, not 
because their ability to synthesize VitD3 in their skin is hampered, but because VitD, a fat-
soluble vitamin, is retained in fat cells, hence the circulating 25(OH)D3 is lower (Christakos et 
al., 2010; Wortsman, Matsuoka, Chen, Lu, & Holick, 2000). The differences between the 
findings in this study and those from others, might be due to other factors (e.g., age, sex, 
different ethnic groups, sun exposure duration, sunscreen use, and VitD intake) affecting the 
potential association between percentage of the body fat mass and VitD3 status, which was not 
evaluated completely in those studies (Andreozzi, Verrusio, Viscogliosi, Luna, & Prof, 2016; 
González, Ramos-trautmann, Díaz-luquis, Pérez, & Palacios, 2015; D. Kim & Kim, 2016). 
In this study, subjects exposed to sunlight below 30 min per day had an 86% likelihood to 
be VitD3 insufficient (OR 1.862, 95% CI 0.960-3.610; P = 0.065), but it did not reach 
significance. In their studies, Bolek-Berquist et al., (2009) reported that 15-30 minutes of 
sunlight exposure daily was not associated with VitD3 status among adults (n=184) in the USA 
(OR 0.81, 95% CI 0.39-1.67, P = 0.61). Similarly, Hayek et al., (2018) reported that sunlight 
exposure 16–60 min was not associated with VitD3 status among adults (n=344) in Lebanon (OR 
1.27, 95% CI 0.670-2.413, P = 0.463). Many factors may influence the cutaneous synthesis of 
VitD3 such as skin color, time of exposure to sunlight, geographical location, and the use of 
sunscreen. Reports including sun exposure measurement have been found to be quite variable in 
the literature (Diana & Antoine, 2015; Harris & Dawson-hughes, 2007; Matsuoka, Wortsman, & 
Hollis, 1990). Thus, better tools (i.e., surveys or devices) are needed to measure sun exposure. 
Due to milk fortification laws in several countries (i.e., with vitamin D3), it has been 
reported that milk consumption is associated with higher VitD3 status (Calvo, Whiting, & 





consumption of milk products on a daily basis and reported a positive association (OR 1.0, 95% 
1.4-1.9, P < 0.001). Their analyses were based on consuming or not consuming milk products on 
a daily basis compared to portions of liquid milk consumed in a week as in this study, which 
might be the reason for their findings. In the present study, those who reported daily ingestion of 
fewer than two servings of milk of were as likely to be VitD3 insufficient as those who reported 
more servings per day (OR 1.246, 95% CI 0.630-2.464, P = 0.527). Consistent with our findings 
in another study, it was reported that high consumption of milk intake was not associated with 
low VitD3 status among 302 subjects in the United States (61% female). They found those who 
consumed milk had 35 ± 10 ng/mL 25(OH)D3 which was not different to those not consuming 
milk 33 ± 10 ng/mL (P = 0.30) (Vin Tangpricha et al., 2002). In Saudi Arabia, most of the dairy 
products are not fortified, which could explain the findings from this study. 
 
Bioefficacy of vitamin D3 in SPNEs 
Consumption of VitD3 supplemented yogurt for two weeks, either from VIDROP or in 
SPNEs, resulted in higher VitD3 status in adult subjects. Forty-six out of 212 subjects who 
participated in the screening matched the inclusion criteria and completed the bioefficacy study, 
but seven participants dropped out of the study for several reasons such as the inability to finish the 
study due to traveling (n=4) and limited transportation (n=3). The age range of the participants was 
18 to 45 years old. From baseline to the end of the study, the placebo group slightly increased the 
serum 25(OH)D3 levels from 29.05 ± 8.82 to 29.66 ± 8.63, (P = 0.002), the VIDROP positive 
control group increased their levels from 29.88 ± 8.93 to 34.46 ± 7.51 (P = 0.001), and the VitD3 
in SPNEs group increased their levels from 29.43 ± 8.88 to 44.34 ± 7.35 (P = 0.001) (Figure 





It has been established, to some extent, that reduction in the particle size of fat-soluble 
nutrients and bioactives results in higher bioaccessibility and bioavailability (Öztürk, 2017). 
Nonetheless, a direct comparison of the findings of this study (i.e., delivery of VitD3 nanoparticles 
to humans) with the current literature is not possible. The author has drawn some comparisons 
associated with the reduction in particle size and enhanced absorption of nutrients and bioactives, 
other than VitD, from pre-clinical and clinical studies.  
In a small controlled clinical trial, Vishwanathan et al. (2009) reported higher 
bioavailability of nano-sized lutein in adults volunteers (n=23, 25-65 years) after consumption of 
orange juice containing lutein in nanoemulsions (d= 150 nm) against control with a higher particle 
size (d = 3,449 nm). In their studies, the serum lutein concentrations increased by 167% in the 
nanoemulsion group, whereas only 104% increase was observed in the lutein supplement group 
with a higher particle size (Vishwanathan, Wilson, & Nicolosi, 2009). In their study, the authors 
prepared lutein-containing nanoemulsions by mixing 0.67 g of Xangold, 15% oil, and 12 drops of 
natural vitamin E oil and subjecting this blend to particle reduction in a microfluidizer. In another 
study, Pereira et al., (2014) reported ~80% relative bioavailability of nano-Fe(III) (d < 10 nm) in 
pre-menopausal female subjects (n=26, 18–45 years) with mild-moderately iron deficient in U.K. 
The subjects ingested a single dose of nan-Fe(III) (58 ± 7 mg elemental iron equivalent) in two 
visits (day 1 and day 14). The nano-Fe(III) were prepared by adding Fe(III) chloride to the solution 
containing a buffer, ligand, and 0.9% (w/v) of electrolyte (i. e., NaCl). Then, they increased the pH 
from 2.0 to 7.4 by the addition of a few drops of NaOH. The solution was filtered and followed by 
one H2OUHP wash was applied to remove excess soluble ligand and non-adsorbed or non-bound to 





show that reduction in particle size increases the absorption of bioactives such as lutein and 
minerals such as iron.  
The evidence from pre-clinical trials is more abundant and conclusive. Using the same 
particle reduction and stabilization process (i.e. ultrasound and pH shift), Almajwal et al., (2019) 
showed that dietary delivery of VitD3 dispersed in pea protein isolate (PPI) enhanced the 
bioefficacy of VitD3 and improved the biomarkers of bone resorption in a rat model of VitDD 
(Almajwal et al., 2019). In a pharmacokinetic study conducted on rats, Kadappan et al., (2018) 
evaluated the bioavailability of nanoemulsions-based delivery of VitD3 in mice prepared by corn 
oil mixed with VitD3 and Quillaja saponin (coarse emulsions) using a high-speed mixer and 
high-pressure homogenizer. Their studies demonstrated that quillaja saponin-nanoemulsions 
containing VitD3 (d < 40 nm) increased the serum concentration of 25(OH)D3 by 73.10% (13.1 ± 
0.09 vs. 22.7 ± 1.10 ng/mL, P < 0.01) showing that the reduction of the nanoparticle size 
improves the bioavailability. Moreover, Lee et al. (2011) showed that the oral delivery of 
nanoemulsions of a vitamin mixture (vitamins A, D, and E) in rats increased the plasma 
concentration AUC compared controls. In this study, the nanoemulsions particle size was (d  
100 nm) which could enhance the absorption due to its active ingredient larger surface. 
Previously, nanoemulsion delivery systems have been shown to enhance the bioavailability of 
nutrients such as coenzyme Q10 and calcium (Chen, Chang, & Wu, 2008; Hatanaka, Kimura, Lai-
fu, Onoue, & Yamada, 2008). Pre-clinical studies showed the nanoemulsions delivery improved 
the bioactivity of insulin, an increase of anti-cancer activity of drugs such as dacarbazine and 
tamoxifen, and improved the anti-inflammatory property of aspirin (Pinto, Veiga, & Neufeld, 





that toxicity reduced, improved bioavailability, and efficacy in a pilot clinical study (Pires, Hegg, 
Valduga, De, & Maranha, 2009). 
Salvia-Trujillo et al., (2017) reported some inconsistent findings from in vivo and in vitro 
studies using VitD2 encapsulated in three emulsions (d 112-14,500) prepared by corn oil mixed 
with VitD2 as a lipid phase and Tween 80 dissolved in sterile phosphate saline buffer (pH 7.4) 
using a high-speed blender. Their studies were not able to determine the change of the VitD2 
levels in the blood using an animal model because a droplet aggregation occurred and they 
measured it by only a single time point after the ingestions of the VitD2 enriched emulsions (L. 
Salvia-Trujillo, Fumiaki, Park, & McClements, 2017). 
In the present study, the higher bioavailability of VitD3 in SPNEs could have been due to 
two reasons. First, the small droplets of the nanoemulsions (d < 100 nm) increase the 
bioavailability of the encapsulated lipophilic elements (McClements & Rao, 2011). In several 
studies, in animals and humans, the reduction in particle size to the nano range as in the 
nanoparticles (d < 400 nm) has facilitated the entrance of the bioactive molecule into the mucous 
layer coating the enterocytes (Hua, Marks, Schneider, & Keely, 2015). Another theory for the 
enhanced absorption has to do with the formulations transit time. The gastrointestinal transit 
mechanisms are very complicated and affected by many factors, ranging from intra- and inter-
individual variability in digestive physiology, the absence or presence of food, and the 
formulation type and size (Varum, Hatton, & Basit, 2013). This can influence the degree and rate 
of the enzymatic hydrolysis of digestible lipids. It is possible that the dispersion of VitD3 in 
SPNEs increased their transit time in the GI tract. This increase in the transit time might have 
allowed a large fraction of the bioactive component to be absorbed by enterocytes and 





In the gut, the absorption of nanoemulsion droplets may occur in two types of cells: M-
cells and epithelium cells. M-cells are assumed to be very effective at absorbing nanoparticles, 
but they are less than 1% of the total intestine area than epithelium cells. The M-cells are 
efficient for absorbing various kinds of antigens, including, microorganisms, macromolecules, 
and several types of particles, which are then passed to the lymphoid system to stimulate immune 
responses. Instead, epithelial cells are the most abundant cell type lining the gastrointestinal tract, 
but they are not considered to be effective in the absorption of particles (des Rieux et al., 2006). 
Currently, there are little experimental data on the primary absorption of nanoemulsion particles 
through epithelium cells, and more work is certainly required. The physicochemical 
characteristics of the nanoemulsion droplets might be changed as they move through the 
gastrointestinal tract (e.g., composition, aggregation state, nano-sized, and charge), and these 
variables must be taken in consideration when examining the nanoparticles absorption 
mechanisms (McClements & Rao, 2011). In the case of this study, the assumption is that soy 
protein nanoparticles are digested through similar routes in the stomach and intestine. During this 
digestion process, the nutrient or bioactive of interest will be released and start its incorporation 
into micelles (Figure 4.5). This process is known to be facilitated by the particle size. After 
VitD3 is incorporated into micelles, it enters the enterocyte via facilitated diffusion. There, it is 
bound to VitD3 binding protein and incorporated into chylomicrons (Öztürk, 2017). Though 
unlikely, the author cannot reject the hypothesis of a potential transfer of undigested SPNEs with 
VitD3 directly into the circulation via M-cells or other cells in the gastrointestinal tract.  
The present study has some limitations that need to be acknowledged. The study sample 
size was small, and the results cannot be generalized to the population at large due to many 





population. The subjects were from King Saud University campus, where their’ education level 
and health awareness are higher than in other parts of the city. The dose provided was a 
supplemental dose. The VitD questionnaire is not validated in Saudi Arabia. More studies should 
be conducted to evaluate the pharmacokinetics of VitD3 in soy nanoparticles in humans. 
 
Conclusions 
The findings presented in this pilot clinical study suggest consumption of VitD3 dispersed 
in SPNEs and mixed in drinkable yogurt resulted in increased absorption of VitD3 represented as 
25(OH)D3 in the serum of subjects with VitD3 insufficiency. It is possible that the small particle 
size might have affected the transfer of VitD3 into micelles in the gut, followed by a more 
efficient absorption. The present study could not identify behaviors associated with low VitD3 
status using a VitD questionnaire. 
The food nanotechnology area is encountering major growth due to the confluence of 
interests of academia, government, the food, and pharma industries. Further studies on nano-
formulations technologies and their clinical application are needed to expand the findings 
presented here. This will support the continuous development of a highly effective and stable food 
micronutrient delivery technology as an alternative strategy that can be used to improve VitD3 
status among at-risk populations. Also, these findings should be followed by larger controlled, 









Tables and Figures 
Table 4.1: Subjects randomization based on baseline 25(OH)D3 value, sex, age groups, and BMI. 
Parameters Placebo Group VIDROP Group VitD3 in SPNEs 
Treatment Group 
N 13 13 13 
Sex (%Female) 54 46 46 
Serum 25(OH)D3 ng/mL 
(mean ± SD) 





































Table 4.2: Subject demographics and answers to Vitamin D status questionnaire. 
 
Characteristics Participants  Characteristics Participants 
Sample size n=212  Milk servings/day (SD) 1.1 (0.75) 
Serum 25(OH)D3, ng/mL 
(Mean ± SD) 
54.33 ± 20.8 
 
Multivitamins*  
Vitamin D insufficiency   Yes 69 (32.5%) 
Yes 55 (25.9%)  No 143 (67.5%) 
No 157 (74.1%)  Vitamin D supplement* 
 
Age groups, years    Yes 20 (9.43%) 
18 - 24 161 (75.9%)  No 192 (90.5%) 
25 - 34 30 (14.2%)  Eggs* 
 
35 - 45 21 (9.9%)  Yes 162 (76.4%) 
Sex   No 48 (22.6%) 
Female 74 (34.9%)  Tuna** 
 
Male  138 (65.1%)  Yes 74 (34.9%) 
Race   No 136 (64.2%) 
Asian 6 (2.82%)  Salmon** 
 
African American 2 (0.94%)  Yes 22 (10.4%) 
White 204 (96.2%)  No 188 (88.7%) 
Education level   Mushroom** 
 
High school 28 (13.2%)  Yes 23 (10.8%) 
Associate degree certificate 11 (5.18%)  No 187 (88.2%) 
Bachelor’s degree 156 (73.6%)  Cod liver or fish oil** 
 
Master’s degree 6 (28.3%)  Yes 19 (8.96%) 
Philosophy of Doctors 9 (4.24%)  No 193 (91.1%) 
No answer 2 (0.94%)  Sun Tan 
 
Marital status   Yes 9 (4.24%) 
Single 161 (75.9%)  No 203 (95.8%) 
Married 47 (22.1%)  Sunscreen 
 
Divorced 2 (0.94%)  Yes 44 (20.8%) 
Employment status   No 168 (77.8%) 
None 5 (2.4%)  Sun exposure 
 
Employee 45 (21.2%)  <30 min/day 128 (60.4%) 
Self – employed 4 (1.9%)  >30 min/day 82 (38.7%) 
Student 156 (73.6)  Tanning both 
 
Annual income in U.S dollars   Yes 1 (0.47%) 
<21.3 191 (90.1%)  No 211 (99.5%) 
21.3 – 32 11 (5.2%)  Chronic intestinal disorder 
 
32 – 42.66 4 (1.9%)  Yes 25 (11.8%) 
>42.66 4 (1.9%)  No 132 (62.2%) 
BMI   Recent diarrhea 
 
Underweight 4 (1.9%)  Yes 27 (13.7%) 
Normal 55 (25.9%)  No 130 (61.3%) 
Overweight 82 (38.7%)  BFM% (Mean ± SD) 27.02 ±10.05 






Table 4.3: Serum 25(OH)D3 in subjects with and without Vitamin D Insufficiency (Wilcoxon signed-




Serum 25(OH)D3, ng/mL 
Vitamin D insufficient  
n= 55 
Vitamin D sufficient  
n= 157 
P-value 
All subjects, mean (SD) 28.62 (8.35) 63.34 (15.61) <0.001 
Age groups, years N (%) 
   
18 - 24  43 (20.28) 118 (55.66) <0.001 
25 - 34  8 (3.77) 22 (10.37) <0.001 
35 - 45  4 (1.88) 17 (8.01) <0.001 
Male N (%), mean (SD) ng/mL 34 (24.6), 28.92 (7.83) 104 (75.4%), 62.86 (15.65) <0.001 
Female N (%), mean (SD) ng/mL 21 (28.4), 34.08 (21.62) 53 (71.6%), 63.01 (14.51) 0.005 
Race, mean (SD) 
   
Asian  20.37 (.)a 58.85 (.)a . 
African  25.94 (.)a 100.89 (.)a . 
White  28.82 (8.42) 63.24 (15.55) <0.001 
Education level, mean (SD) 
   
High school 31.15 (9.39) 54.48 (14.7) 0.028 
Associate degree certificate 22.82 (6.25) 62.08 (8.53) 0.068 
Bachelor’s degree 28.81 (8.48) 64.64 (15.55) . 
Master’s degree 0.0 (.) 66.42 (18.75) <0.001 
Philosophy of Doctors degree 28.65 (7.14) 69.8 (15.97) 0.068 
Marital status, mean (SD) 
   
Single 28.72 (8.49) 62.92 (16.1) <0.001 
Married 29.04 (8.07) 64.38 (13.98) 0.002 
Divorced 19.2 (.)a 77.76 (.)a . 
Employment status, mean (SD) 
   
Employee 29.32 (8.40) 64.82 (13.76) 0.003 
Self – employed 0.0 (.)a 69.16 (12.49) . 
Student 27.89 (8.4) 61.44 (16.22) <0.001 
None 0.0 (.)a 76.44 (19.84) . 
Annual income in $(1000), mean 
(SD) 
   
<21.3 28.61 (8.5) 63.41 (15.81) <0.001 
21.3 – 32 0.0 (.)a 60.45 (11.82 . 
32 – 42.66 32.31 (9.96) 79.47 (25.97) 0.18 
>42.66 24.99 (0.17) 57.94 (0.94) 0.18 
BMI, mean (SD) 
   
Underweight  0.0 (.)a 62.67 (8) . 
Normal 25.57 (8.88) 62.92 (16.3) <0.001 
Overweight 32.62 (6.67) 64.03 (16.11) <0.001 
Obese 26.6 (8.23) 62.88 (15.18) <0.001 
Multivitamins    
Yes 32.28 (8.17) 62.85 (15.51) 0.003 






Table 4.3: (cont.): Serum 25(OH)D3 in subjects with and without Vitamin D Insufficiency.  
 
Characteristics 
Serum 25(OH)D3, ng/mL 
Vitamin D insufficient 
n= 55 
Vitamin D sufficient 
n= 157 
P-value 
Milk consumption   
  
< 2 servings/day 29.05 (8.19) 63.62 (15.73) <0.001 
> 2 servings/day 27.46(8.9) 62.72(15.49) <0.001 
Vitamin D supplement 
   
Yes 30.6 (4.75) 63.22 (18.85) 0.109 
No 28.5 (8.53) 63.35 (15.16) <0.001 
Eggs 
   
Daily 29.34 (8.36) 61.6 (16.19) <0.001 
Weekly 29.43 (8.25) 62.31 (14.84) <0.001 
No 25.15 (8.53) 67.52 (15.45) 0.005 
Tuna 
   
Weekly 31.45 (6.68) 63.43 (15.5) <0.001 
No 26.58 (8.92) 63.29 (15.73) <0.001 
Mushroom 
   
Weekly 29.21 (8.5)  60.69 (15.04) 0.068 
No 28.57 (8.42) 63.7 (15.7) <0.001 
Salmon 
   
Weekly 36.14 (4.15) 61.92 (16.49) 0.109 
No 28.42 (8.44) 63.7 (15.47) <0.001 
Cod liver or fish oil 
   
Yes 0 (.)a 58.99 (11.81) . 
No 28.62 (8.35) 63.97 (16.02) <0.001 
Caviar 
   
Weekly 19.2 (.)a 77.78 (.)a . 
No 28.79 (8.33) 63.24 (15.61) <0.001 
Sun exposure 
   
<30 min/day  39 (18.39%) 89 (41.98%) <0.001 
>30 min/day 16 (7.54%) 68 (32.07%) <0.001 
Sunscreen 
   
Yes 30.31 (10.32) 61.79 (15.81) 0.028 
No 28.41 (8.18) 63.83 (15.58) <0.001 
Tanning booth 
   
Yes 14.56 (.)a 74.21 (.)a . 
No 28.62 (8.35) 63.27 (15.63) <0.001 
Suntan in the past 12 months 
   
Yes 32.15 (1.67) 65.72 (12.93) 0.18 
No 28.48 (8.48) 63.47 (15.99) <0.001 
Chronic intestinal disorder 
   
Yes 30.13 (10.68) 61.98 (42.42) 0.068 
No 28.4 (8.32) 63.36 (16.04) <0.001 
Recent diarrhea 
   
Yes 35.62 (3.22) 60.15 (16.21) 0.18 
No 28.15 (8.33) 63.84 (15.55) <0.001 





Table 4.4: Results of multiple logistic regression model for 25-hydroxyvitamin D level ≤ 40 ng/mL 
Demographic Variables Odds Ratio (95% CI) P-value 
Gender (F/M)  1.212 (0.641, 2.290) 0.553 
Age 
Age group (18-24/25-34) 
Age group (25-34/35-45) 
Age group (18-24/35-45) 
 
Sun Seeking Habits 
Tan in the past 12 months (Yes/No) 
Tanning booth (Yes/No) 
Sunscreen (Yes/No) 
Sun exposure time 
(Morning/Afternoon) 










Cod liver or fish oil (Yes/No) 
Multivitamins (Yes/No) 
Vitamin D supplements (Yes/No) 
 
Diseases 
    Chronic intestinal diseases (Yes/No) 
    Recent diarrhea (Yes/No) 
 
1.002 (0.415, 2.419) 
1.545 (0.397, 6.002) 
1.548 (0.493, 4.860) 
 
 
0.808 (0.162, 4.014) 
0.939 (0.037, 23.41) 
0.820 (0.500, 1.343) 
1.589 (0.856, 2.947)   
 




1.246 (0.630, 2.464) 
0.845 (0.425, 1.682) 
0.650 (0.345, 1.223) 
1.755 (0.569, 5.407) 
0.346 (0.021, 5.630) 
2.386 (0.677, 8.402) 
0.060 (0.003, 1.016) 
0.369 (0.173, 0.787) 
0.395 (0.112, 1.386) 
 
 
0.414 (0.137, 1.248) 





























BMI (<25/>25) 1.071 (0.539, 2.129) 0.843 
BFM*   
Males (None-Obese/Obese) 
Females (None-Obese/Obese) 
0.651 (0.298, 1.419) 




*The cutoff points from Gallagher et al., (2000) were adjusted for the percentage of body fat and used to 









Figure 4.1: Preparation of soy protein isolate nanoemulsions (SPNEs) containing VitD3 by using pH 




































Figure 4.3: Effect of two types of products containing VitD3 (100 µg) delivered in drinkable yogurt three 
times a week (every other day) for two weeks on serum 25(OH)VitD3 status among subjects with VitD3 
insufficiency. Placebo (n=13) did not receive VitD3; VIDROP (n=13) was the positive control and 
received drinkable yogurt containing VIDROP (100 µg), and VitD3 in SPNEs (n=13) received drinkable 
yogurt containing VitD3 dispersed in soy protein nanoparticles. Bars represent Means ± SD. Bars with 






























Figure 4.4: Effect (percent change) of two types of products containing VitD3 (100 µg) delivered in 
drinkable yogurt three times a week (every other day) for two weeks on serum 25(OH)VitD3 status among 
subjects with VitD3 insufficiency. Bars represent Means ± SD. Bars with different superscripts represent 






























































Figure 4.5: Schematic of the mechanisms of active ingredient uptake using nanocarriers systems. 
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CHAPTER 5: SENSORY AND PHYSICOCHEMICAL CHARACTERISTICS OF 
DRINKABLE YOGURT FORTIFIED WITH SOY PROTEIN NANOEMULSIONS 
CONTAINING VITAMIN D3 
ABSTRACT 
BACKGROUND: Vitamin D (VitD) deficiency and insufficiency are prevalent in Middle 
Eastern countries. Fortification of dairy products is an effective strategy to address dietary 
deficiencies of VitD3. Nano-encapsulation can enhance the absorption of nutrients. Thus, the 
development of fortified products containing food-, protein-based nanoparticles is an area of 
continuous exploration.  
OBJECTIVE: To determine if there is a sensory difference between two products (i.e., fortified 
drinkable yogurt with SPNEs containing VitD3 vs. a control without fortification) and to evaluate 
the physicochemical characteristics including viscosity, acidity, pH, and colors differences under 
a combination of normal and abnormal temperature and storage time conditions. 
METHODS: SPNEs was prepared by dispersing soy protein isolate in deionized water (3%, 
w/v), and the addition of canola oil (1%, w/w) loaded with VitD3 (100 g/mL; cholecalciferol) 
after pH shifting and ultrasonication method. Triangle test with three replications was performed 
with adults (n=62) in a sensory room to evaluate the sensory differences between a control and 
the SPNEs fortified yogurt. For the physicochemical characteristics of drinkable yogurt fortified 
with SPNEs containing VitD3, samples were exposed at 4 and 23 °C, collected at three-time 





RESULTS: Based on the sensory discriminatory analysis, drinkable yogurt fortified with SPNEs 
containing VitD3 was not different from the unfortified control (P = 0.5). The addition of SPNEs 
containing VitD3 into the drinkable yogurt resulted in no apparent differences in terms of their 
physicochemical characteristics at any of the time points during storage at 4 °C and 23 °C (P > 
0.05). 
CONCLUSIONS: The addition of SPNEs loaded with VitD3 to drinkable yogurt is technically 
feasible and did not result in changes associated with its physicochemical and sensory 
characteristics. The fortification of drinkable yogurt with SPNEs containing VitD3 could 
successfully serve as a potential nano-delivery system for enhancing VitD3 content without 
changes in the quality characteristics. 
 



















Food fortification of staples is one of the most cost-effective strategies to deliver and 
maintain adequate nutrition to the population at large, especially to those at-risk groups (Allen, de 
Benoist, Dary, & Hurrel 2006). In Saudi Arabia, vitamin D (VitD3) deficiency and insufficiency are 
prevalent, especially among women and young children (N. A. Al Jurayyan et al., 2012; AlBuhairan 
et al., 2015; Ardawi et al., 2011b). To address these nutrient gaps, several food products are fortified 
with micronutrients such as iron, niacin, folic acid, vitamin A and VitD3. Although available 
products could provide excellent nutrition to populations, many products do not address the 
physiological status of individuals, their cultural habits, and socio-economic conditions. Moreover, 
most food vehicles that deliver VitD3 are based on fluid milk. Some population groups might not 
consume it due to lactose intolerance and other preferences. Thus, new technologies should 
overcome the shortcomings of current products and thus improve the diversity of offerings via food 
vehicles that could prove useful to improve VitD3 status among populations.  
Delivering adequate nutrition to specific groups and facilitating functional food access to a 
larger audience has become a new priority for the food industry (Sloan & Hutt, 2012). Addition of 
bioactives and nutrients, however, is not a straightforward process. Bringing new ingredients into a 
food recipe often leads to food deterioration and rapid spoilage, changes in rheology, modifications 
in sensory attributes, changes in consumption habits and preparation, and interactions with other 
food ingredients; thereby reducing the intended beneficial effect (Guiné, Ramalhosa, & Valente, 
2016). The technical feasibility of the chosen product and the fortificant are some of the many 
factors that determine the success of the fortification process, which includes the level of 
fortification, the consumption pattern, the interactions among nutrients, the stability of premixes, 





 Among current technologies to address the addition of molecules into food systems, 
encapsulation has become a suitable technology for the delivery of many forms of nutrients, 
bioactives, and flavors. The benefits of encapsulation via micro- or nano-particles made of synthetic 
or naturally occurring molecules (e.g., protein, carbohydrates, and fats) include protection of 
sensitive components and their function, and facilitating the targeted release of molecules (Mahmoud 
et al., 2015). A variety of methods for encapsulation have been demonstrated, requiring additional 
energy input and with varying degrees of success. One of the key factors is that encapsulation 
strategies must vary due to both, the system of dispersal (i.e., the carrier) and the bioactive 
component itself (i.e., the cargo). Although there have been several creative strategies for the 
protection and delivery of bioactive food components, still there are many questions regarding the 
impact of these delivery systems on the efficacy of the nutritional intervention and their effect on the 
final product characteristics. It has been proposed that nanotechnology applied to encapsulation can 
solve some of these problems, especially high dispersion, high bioavailability, and low effects on 
quality; yielding increased benefits to the public at large (L. Chen et al., 2006; Sozer & Kokini, 
2009). 
In this study, the author evaluated the technical feasibility of fortifying drinkable yogurt as a 
potential vehicle for the delivery of VitD3 loaded in SPNEs for populations in Saudi Arabia. The 
author evaluated the fortified product in terms of changes in sensory and physicochemical 
properties. 
 
Materials and Methods 





The pH shifting and ultrasonication method is described in Lee et al., (2016). Briefly, the 
soy protein isolate (SPI, Pro- Fam® 955, 90% on a dry basis) was obtained from Archer Daniels 
Midland (ADM, Decatur, IL, USA). The SPI Pro-Fam 955 is a water-washed intact protein with 
pH 5.0 – 5.5. Canola oil was purchased from a food supplier (Wesson, ConAgra Foods, Omaha, 
NE). A VC-750 ultrasound generator at 20 kHz (Sonics & Materials, Inc., Newtown, CT, USA) 
was used to apply ultrasound treatments (Figure 5.1). SPNEs were made by adding SPI (3 g) to 
100 mL deionized water in a 250 mL beaker (3% w/v) and stirred for 30 min at room 
temperature with a magnetic stirrer. The SPI was neutralized to pH 7 with a few drops of 2 M 
NaOH, and then it was adjusted to pH 12 with 2 M NaOH followed by sonication for five 
minutes. During sonication, the beaker was placed in an ice bath to control the temperature of the 
sample below 50 oC. Then, samples were stored for 1 hour at room temperature. Samples were 
neutralized to pH 7 with 2 M HCl followed by sonication. Neutralized SPI dispersions were 
centrifuged (1,200 × g and 20 oC) for 15 min. VitD3 powder (cholecalciferol) was obtained from 
Sigma-Aldrich (St. Louis, MO, USA¸ ≥ 98% purity) and dissolved in canola oil (8 mg of VitD3 
and 1 g canola oil). VitD3 powder with an amount of 8 mg was mixed in 1 g canola oil and 
sonicated for 10 min in an ultrasonic bath until VitD3 was completely dissolved in oil. Then, it 
was added to 100 mL of SPI nanoparticle dispersion after stabilization. The contents were 
thoroughly mixed by vortex for 10 min. Then, the SPI nanoemulsions (SPNEs) containing VitD3 
were treated with ultrasonication similar to before as shown in Figure 5.2. SPNEs containing 
VitD3 were freeze-dried (Labconco Freeze Dryer FreeZone 6 Liter, USA) for four days and 







Preparation of fortified drinkable yogurt 
Dry SPNEs containing VitD3 was mixed with the yogurt on the day of the sensory test. 
The intrinsic concentration of VitD3 in the yogurt was 0.845 µg/100 mL. The concentration of 
VitD3 in the SPNEs was 2.1 µg/mg (84 IU/mg). The final dose of VitD3 in SPNEs dispersed in 
100 mL of yogurt was 168 IU (4.2 µg). Thus, the total dose of VitD3 from the SPNEs and the 
yogurt was 5.04 µg/100 mL (201.8 IU). This amount (100 mL) contributes to 33.6% of the RDA 
for children and adults (15 µg/day). SPNEs added to yogurt was accurately weighed (one 
thousandth) and then added to 100 mL of yogurt. This sample was mixed thoroughly for 5 
minutes. Then, the 50 mL sample was mixed with the final volume of yogurt for 1 minute by 
gently inverting the bottle of yogurt. This process generated some gas bubbles. Thus, the control 
was treated in the same manner to avoid any potential confounding effect.  
 
Sensory evaluation 
Human Subjects. All studies with human subjects were submitted for review and 
approval before their implementation by the Institutional Review Board (IRB) at the University 
of Illinois at Urbana-Champaign (IRB approval #18615, appendix H). Participants were 
recruited from the local population in the Department of Food Science and Human Nutrition at 
the University of Illinois. Recruitment fliers were posted in several locations to promote 
participation. The sensory test was conducted in the Sensory Analysis Laboratory at UIUC.  
Triangle test. A triangle test was used to evaluate differences between yogurt fortified 





provided to the participants at random. There were three sets of samples, and each set had three 
coded samples. In each set, two samples are identical, and one is different (Figure 5.3).  
Sensory test procedure. Upon their arrival, participants were asked to seat in one of the 
nine cabins equipped with indicator lights (i.e., to call the investigator) in case the participant had 
questions. White light was used in all sensory cubicles. On the test area, participants received 
first the consent form (Appendix I). Once participants had consented and called the investigator, 
they received the sample tray through a sliding door directly in front of them along with 
instructions to conduct the test (Appendix J) and a demographic information questionnaire 
(Appendix K). Figure 5.4 shows the sample tray, water cup, rinsing cup, instruction form, and 
crackers. Subjects only received three sets of the six potential sets of samples at random (Figure 
5.4). 
Subjects were asked to identify the odd sample among each of the three sets by checking 
the box under the code (Appendix J). Subjects were asked to test each set of three samples from 
left to right and top to bottom (Figure 5.4).  After testing each set of samples (three per set), 
subjects were asked to eat a cracker and rinse their mouths with water. Upon termination, the 
subjects received a gift card for their participation valued at $5. The area was thoroughly cleaned 
before another participant started the test. 
Food and materials. Drinkable yogurt was purchased from Ziyad Brothers (Illinois, 
USA). Clear cups (60 mL) with lids (No. PL200N) were purchased from Dart Container 
Corporation (Mason, Michigan, USA). Unsalted crackers were purchased from Amazon 
(NABISCO, Mondelez Global LLC, New Jersey, USA). Cups for rinsing (473 mL) and drinking 
(237 mL) were purchased from Dart Container Corporation, (Mason, Michigan, USA). 





week before the sensory test. Fortified yogurt was prepared on the same day in the food grade 
sensory laboratory and stored in a refrigerator. Cups with samples were labeled with 3-digit 
codes at random. The sensory test room has no direct access to the preparation room with a 
temperature of 20 ± 3°C. The preparation of the tray with three sets of nine samples (Figure 5.3) 
took place in the food grade room.  
 
Physicochemical characteristics 
Titratable acidity, pH, viscosity and color were evaluated in fortified and control samples 
stored at 4 and 23 °C and sampled at three-time points (0, 24, 48 hours). Samples were stored in 
glass containers with lids purchased from (Ball Corporation, USA) covered with aluminum foil 
and lids. The headspace was reduced as much as possible. 
Titratable acidity. The method number 947.05 was used (AOAC, 1990). Briefly, samples 
(10 mL) were titrated with 0.1 N  NaOH solution and using phenylalanine as an indicator 
(AOAC, 1990). The titratable acidity was examined by filling a 100 mL burette with 0.1 N 
NaOH. Then, 10 g of drinkable yogurt, 30 mL deionized distilled water, and 1 mL 
phenolphthalein was mixed in a 250 mL Erlenmeyer flask. The mixture was shaken well under a 
constant stream of NaOH until a pink endpoint was held for at least 10 seconds. % lactic acid 
(equivalents) was calculated using Equation 1: 
Lactic acid (%)= 
 V 0.1 N NaOH x N x MW x 100
W x 1000
 
where, V is the volume in mL of the standard NaOH used for titration; N is the normality 
of standard NaOH solution; MW is the molecular weight of lactic acid (~90 g/L), and W is the 





pH. This parameter was measured using a pH meter (Fisher Scientific, USA) in samples 
(50 g) at room temperature (23 °C). The pH meter was calibrated (pH 4 and 7), the probe was 
rinsed completely with deionized water, and the probe was located into the middle of the sample. 
Stable reading was recorded after reaching stabilization. 
Viscosity. A Brookfield RVDVE viscometer (Middleboro, MA, USA) was used to 
measure the viscosity of fortified and unfortified samples. Each sample (10 g) was added to the 
sample container and allowed to stand for 60 s before measures were obtained. Results were 
taken at 100 rpm and expressed in centipoise (cP) in a maintained temperature at 23 °C.  
Color. A HunterLab colorimeter (LabScan XE spectrophotometer; Hunter Associates 
Laboratory Inc., Reston, VA, USA) was used to measure color parameters. Samples (50 g) were 
placed in the colorimeter cup, and the color parameters [L* degree of brightness, a* degree of 
redness (+) or greenness (-), and b* the degree of yellowness (+) or blueness (-)] were measured. 
The ΔE difference between the fortified samples and controls was calculated by the following 
equation:  
ΔE =  √(𝐿0 − 𝐿1)^2 − (𝑎0 − 𝑎1)^2 − (𝑏0 − 𝑏1)^2 
The superscript (0) represents the control yogurt, and the superscript (1) represents the fortified 
yogurt with SPNEs loaded with VitD3. The net color differences ΔE was interpreted using the 
following classification (Vichi, Ferrari, and Davidson, 2000): 
 ΔE value < 1 is not perceptible by human eyes 
 ΔE value > 1 and < 2 is perceptible through close observation 






For the triangle test, data were analyzed using IFProgramsTM version 9 (the Institute for 
Perception, USA). Power was determined using the calculated overdispersion, three replications, 
alpha of 0.05, and a null probability of 1/3. Data from titratable acidity, pH, and viscosity were 
analyzed by three-way analysis of variance (ANOVA) (i.e., fortification treatment, storage time, 
and storage temperature). The Tukey’s Honest Significant Difference test was used to compare 
means. Statistical significance was established at an alpha of 0.05. 
 
Result and Discussion 
The literature is limited on the use of nano-formulations containing vitamins in 
fortification. Thus, in the next paragraphs, the author offers reviews of several studies in an 
attempt to explain the findings associated with sensory and physicochemical effects.  
 
Sensory evaluation 
A total of 62 participants finished the study (69.4% of females vs. 30.6% males). As 
shown in Figure 5.5, one-third of the 62 participants were from countries in which drinkable 
yogurt is consumed frequently. Low-fat drinkable yogurt was the most consumed type among 
participants (Table 5.1). Based on the sensory evaluation, the drinkable fortified yogurt with 
SPNEs containing VitD3 was not different from the control (p = 0.5) with a less sensitivity 
overdispersion in judges’ decisions due to the replicates (γ = 0.095), and with a power value of 
1.0 which is the probability of declaring a difference when one exists (Ennis, 1999). 





zero representing no overdispersion to one indicating total overdispersion (Angulo, Lee, & 
O’Mahony, 2007).  
In a recent study, the addition of lipid nano-capsule (LNCs) loaded with VitD3 (d = 31-37 
nm) to milk at a fortification level of 4 µg/100 mL (160 IU) VitD3 resulted in no changes in 
sensory attributes against control as evaluated by trained panelists using a hedonic scale. LNCs 
loaded with VitD3 were prepared by the phase-inversion and temperature method by 
incorporating all components including lecithin, labrafac, NaCl, Solutol HS15, water, and VitD3 
(Kiani, Fathi, & Ghasemi, 2017). Similarly, Hasanvand et al., (2015) evaluated the addition of 
starch nano-carriers (d = 14-32 nm) loaded with VitD3 to milk (0.16%, w/v) and reported no 
sensory differences between the fortified and control samples as evaluated by eight trained 
panelists using a hedonic scale. The starch nano-carriers loaded with VitD3 consisted of high 
amylose corn starch solution in 0.1 M KOH (w/v) and VitD3 dissolved in ethanol and were 
prepared using ultrasound (300-450 W).  
Other related studies on the fortification of dairy products with nanosized ingredients 
showed no effects on sensory attributes. Seo et al., (2011) showed that adding nano-chitosan 
solution (1~7%, v⁄v) to milk did not change its sensory attributes. Ahn, Ganesan and Kwak, 
(2013) showed fortifying milk with small particle size, dry peanut sprouts (d = 300-350 nm) with 
a concentration (1 and 3%, w/v) resulted in no adverse effects on the sensory properties.  
Furthermore, adding micro-encapsulated fish oil powder via complex coacervation with 
gelatin/acacia gum to yogurt was considered acceptable by a group of untrained panelist even 
after 22 days of storage (Tamjidi, Nasirpour, & Shahedi, 2011). Finally, Cueva and Aryana 
(2008) reported that the fortification of yogurt with unencapsulated vitamin B1, vitamin B2, 





respectively), and fiber (176 g/7.570 kg yogurt) resulted no differences in flavor, color, 
appearance, body and texture between the fortified and control samples as evaluated by a set of 
trained judges. Similarly, Gaur, Waller and Andrade, (2019) reported that the fortification of 
chhash (Indian yogurt) with micronutrients (vitamin A, VitD2, folic acid, iron, zinc, and iodine) 
without encapsulation was similar to its counterpart as evaluated by untrained panelists from 
India. These findings show that nano/microencapsulation or just the addition of micronutrients 
into yogurt could be an effective strategy without affecting its sensory attributes.  
 
Changes in physicochemical characteristics 
pH and titratable acidity 
Addition of SPNEs loaded with VitD3 (0.042 µg/mL) did not influence pH or titratable 
acidity at any temperature (4 or 23 °C) and during any sampling period (0, 24 or 48 h) (Figures 
5.6 and 5.7). Titratable acidity and pH fluctuated between 0.95 and 1.01 and 3.73 and 3.81, 
respectively and had no treatment, time or temperature effect. After 24 hours, the pH in SPNEs 
containing VitD3 samples stored at 4 °C increased in less than a percent unit (0.53%), whereas 
the control samples increased by 0.81%. Also, yogurt samples fortified with SPNEs containing 
VitD3 stored at 23 °C increased their pH by 0.80% in contrast with the control samples, which 
remained constant. After 48 hours, SPNEs containing VitD3 samples at 4 °C decreased by 
1.05%, but the control samples increased by 1.07%. At 23 °C, SPNEs containing VitD3 and 
control samples increased by 0.27% (Figure 5.6). Titratable acidity at 4 and 23 °C for all 
treatments increased after 24 hours (between 2-5% from initial). After 48 hours, titratable acidity 





and titratable acidity decrease and increase, respectively after exposure to high temperature over 
time.  
Other related studies on the fortification of dairy products with nano-formulations 
showed no pH differences. Santillan-Urquiza, Mendez-Rojas and Vélez-Ruiz, (2017) reported 
that the fortification of yogurt with nanoparticles of calcium phosphate, iron oxide, and zinc 
oxide coated with inulin (d = 50-80 nm) showed no significant differences in pH values after 
their storage for 28 days at 4 ± 1 °C. The zinc oxide nanoparticles were prepared by mixing zinc 
chloride, methanol, and sodium hydroxide and separated by centrifuge and dried to obtain zinc 
oxide nanoparticles in solid form. The alpha iron oxide was made by incorporating ferric 
chloride, ethanol, ammonium hydroxide, ferrous chloride tetrahydrate, HCl, and deionized water 
and characterized by X-Ray diffraction. Finally, the calcium phosphate nanoparticles were 
prepared by using Tween 80, Aliquat 336, kerosene, calcium nitrate tetrahydrate, and bi-
ammonium hydrogen phosphate and processed by the reverse microemulsion route. Also, 
Ghorbanzade and others (2017) showed that addition of non-liposomal encapsulated fish oil (d = 
300-500 nm) to yogurt did not result in changes to pH or titratable acidity after 21 days of 
storage at 4 °C (Ghorbanzade, Jafari, Akhavan, & Hadavi, 2017). It was noted in another study 
that the pH and titratable acidity of milk samples fortified with ascorbic acid-soluble nano-
chitosan (1~9%, v ⁄ v) were almost constant during 15 days of storage at 4 °C (Seo et al., 2011). 
In studies of micro-encapsulation, Kim et al., (2003) examined the effect of the 
fortification of a yogurt drink with iron and vitamin C (5:1:50 ratio, w/w/v) prepared by 
polyglycerol monostearate as a coating material and Tween 60 as a co-emulsifier its 
physicochemical characteristics. Samples stored at 4 °C for ten days showed no differences in 





from Tamjidi, Nasirpour and Shahedi, (2011) who examined the effect of the addition of 
microencapsulated fish oil by complex coacervation technique to yogurt. Kaushik, Sachdeva and 
Arora, (2017) showed that the fortification of yogurt with calcium (500-600 ppm) and VitD2 
(600 IU/L) micro-encapsulated in a water-soluble coating of cyclodextrins as a wall material did 
not affect the pH and titratable acidity values of fortified samples in comparison to the control.  
In general, the addition of milligram amounts of micronutrients without an encapsulation 
strategy might affect or not the products’ physicochemical characteristics. These changes might 
not affect instead the stability of vitamins in the matrix. As reported by Kazmi et al., (2007), 
VitD3 was stable when added to Cheddar cheese-like matrix, yogurt, and ice cream either as 
crystalline or emulsified form (Kazmi, Vieth, & Rousseau, 2007). Cueva and Aryana (2008) 
studied the effect of the fortification of yogurt with unencapsulated vitamin B1, vitamin B2, 
vitamin B3, vitamin B9, magnesium, manganese (0%, 30%, 60% and 90% of the RDA), and 
fiber (176 g/7.570 kg yogurt) and reported no differences in pH values between the fortified and 
control samples (Cueva & Aryana, 2008). Dianti et al., (2017), however, reported that the 
fortification of goat milk kefir with VitD3 (42 IU/100mL) and B12 (20 µg/100mL) resulted in 
significant differences in pH and titratable acidity values in comparison with the control after 15 
days of storage. Finally, Gaur and others (2019) reported that the fortification of chhash with 
micronutrients (vitamin A, VitD2, folic acid, iron, zinc, and iodine) stored at 4, 23 and 40 °C for 
six days resulted in no effects on pH and titratable acidity values between the fortified samples 
and the control samples (Gaur et al., 2019). Most effects observed in studies of fortification of 
yogurt stored under a combination of temperature and time affected pH (decreased) and titratable 
acidity (increased) independent of the addition of micronutrients (Gaur et al., 2019; Ghorbanzade 





Viscosity and color differences (ΔE)  
The addition of SPNEs containing VitD3 into the drinkable yogurt did not affect its 
viscosity in comparison with control samples at any of the storage temperature and any of the 
time points and had no time or temperature effect (P > 0.05). Viscosity increased for all samples 
due to time and temperature interaction but was not statistically different (P > 0.05). Figure 5.8 
shows changes in viscosity of the fortified drinkable yogurt and the control, which increased 
over time from 1.21 ± 0.06 to 1.52 ± 0.06 and 1.12 ± 0.02 to 1.61 ± 0.06 after two days of 
storage during the storage temperature at 4 °C, respectively. Although, the viscosity of the 
fortified drinkable yogurt and the control, increased over time from 1.21 ± 0.00 to 1.34 ± 0.01 
and 1.16 ± 0.01 to 1.57 ± 0.07 after two days of storage during the storage temperature at 23 °C, 
respectively.  
It has been reported that viscosity in non-fat yogurt increase throughout the storage time 
and due to protein-protein contact and protein rearrangement (Isleten & Karagul-Yuceer, 2006; 
Sahan, Yasar, & Hayaloglu, 2008). Also, the increase of viscosity during storage might be 
related to the production of lactic acid and viscous exopolysaccharides by the lactic acid bacteria 
(Ahn, Ganesan, & Kwak, 2018). Dianti et al., (2017) reported that the fortification of goat milk 
kefir with VitD3 (42 IU/100 mL) and B12 (20 µg/100 mL) showed no significant differences 
between the viscosity values among the fortified samples compared to the control over 15 days. 
Also, Gaur, Waller and Andrade, (2019) reported chhash fortified with unencapsulated 
micronutrients (vitamin A, VitD2, folic acid, iron, zinc, and iodine) stored at 4 and 23 °C for six 
days showed no differences in the viscosity of samples due to fortification only. Cueva and 
Aryana, (2008) studied the effect of the fortification of yogurt with unencapsulated vitamin B1, 





RDA), and fiber (176 g/7.570 kg yogurt) on the viscosity values and found no significant 
differences between the fortified and control samples between days one and seven. Furthermore, 
the fortification of drinkable yogurt with microencapsulated iron and vitamin C (5:1:50 ratio, 
w/w/v) prepared by polyglycerol monostearate as a coating material and Tween 60 as a co-
emulsifier stored at 4 °C for ten days resulted in no differences among the viscosity values (S. J. 
Kim et al., 2003). Tamjidi et al., 2011 reported that the addition of microencapsulated fish oil in 
yogurt during seven days at 4 °C resulted in a slight increase in the viscosity as compared to a 
control.  
The addition of micronutrients can modify the color of foods. Color is an important factor 
that can directly influence the acceptance of a modified food product, especially those that are 
either transparent or white (Spence & Piqueras-fiszman, 2016). The addition of micronutrients 
into foods might negatively affect color, for example, in the case of iron fortification (Abbasi & 
Azari, 2011). In the present study, only the storage time and temperature had an effect on ΔE 
values (Three-way ANOVA, P < 0.05); however, this effect was not linear or followed a specific 
trend (Figure 5.9). These changes, however, are considered not perceptible by human eyes 
according to Vichi, Ferrari and Davidson, (2000). 
The fortification of ascorbic acid-soluble nano-chitosan particles to milk (1~9%, v/v) and 
storage at 4 °C for 15 days did not change the color of the milk (Seo et al., 2011). In a different 
study, the fortification of yogurt with microencapsulated fish oil did not significantly change its 
color (Tamjidi et al., 2011). Addition of several micronutrients (i.e., vitamin A, VitD2, folic acid, 
iron, zinc, and iodine) to chaash (Indian yogurt) stored at 4, 23 and 40 °C for six days increased 
ΔE values as compared with the control. The difference with the present study may be due to 





vitamin A and iron (Kaushik et al., 2017). Similar to the previous studies with multiple 
micronutrients, Cueva and Aryana, (2008) found that addition of unencapsulated vitamin B1, 
vitamin B2, vitamin B3, vitamin B9, magnesium, manganese (0%, 30%, 60% and 90% of the 
RDA), and fiber (176 g/7.570 kg yogurt) to yogurt elicited color changes as compared to the 
control. Abbasi and Azari, (2011) reported that the fortification of milk with microencapsulated 
iron (7 mg /L) prepared by fatty acid esters method using a mixture of polyglycerol 
monostearate, iron salt, and ascorbic acid, and Tween 60 as an emulsifier displayed a significant 
color difference after storage at 4 °C for four days. Based on the ΔE values and the sensory 
results of the present study, it is concluded that the SPNE nanoencapsulation technology for 
VitD3 is not likely to elicit color changes in yogurt. 
The present study has some limitations that need to be acknowledged. The study did not 
try different food with a different pH, optimize the amount of VitD3 in SPNEs in the yogurt, and 
use a higher temperature. Also, it did not compare the control that had SPNEs or that was 
fortified with regular VitD3 unencapsulated. More studies should be conducted to evaluate the 
physicochemical properties of VitD3 in soy nanoparticles.   
 
Conclusions 
Vitamin D deficiency and insufficiency are prevalent in Saudi Arabia. Dairy products are 
broadly used as fortification vehicles for a variety of bioactive ingredients. The use of 
nanotechnology to deliver vitamins might offer several advantages for food companies and has 
not been extensively studied. Dispersion of VitD3 in SPNEs could protect the vitamin and reduce 





designed to evaluate the technical feasibility of the addition of SPNEs containing VitD3 into 
drinkable yogurt in terms of sensory and physicochemical properties. The results indicated that 
the fortification of drinkable yogurt with SPNEs containing VitD3 did not influence viscosity, 
titratable acidity, pH, and the net color differences under two temperatures and during two-days 
of storage. In terms of sensory attributes, the fortified yogurt was virtually identical to the 
unfortified counterpart. Based on these results, it is suggested that the SPNE is a suitable 
delivery system for VitD3 without affecting the sensory and physicochemical properties of 
drinkable yogurt. As the addition of more micronutrients might affect physicochemical 
characteristics of foods, future studies should explore the addition of other micronutrients along 
with SPNEs as well as the nano-emulsification of other fat-soluble vitamins in SPNEs and their 














Table and Figures 
Table 5.1: Demographic characteristics of consumer panelists (n = 62) participating in the sensory 
evaluation of fortified yogurt and responses to vitamin D3 consumption questionnaire. 
Characteristics n (%) Responses n (%) 
Age groups   Ever consumed Yogurt 62 (100) 
18-24 4 (6.5) Often consume Yogurt   
25-30 25 (40.3) Everyday 9 (14.5) 
31-45 27 (43.5) Two times/week 10 (16.1) 
>45 6 (9.7) Three times/week 18 (29) 
    Once a month 22 (35.5) 
Sex   Twice a month 3 (4.8) 
Female 43 (69.4) 
 
  
Male 19 (30.6) Types of yogurt consumed   
    Low fat 46 (74.2) 
Occupation   Nonfat 21 (33.9) 
Student 54 (87.1) Flavored 48 (77.4) 
Faculty/Staff 5 (8.1) Plain 40 (64.5) 
Other 3 (4.8) Whipped 13 (21)   
Custard 9 (14.5) 
Ethnicity   Greek 48 (77.4) 
Asian 33 (53.2) Drinkable 37 (59.7) 
White 24 (38.7) Smoothie 26 (41.9) 
African American 1 (1.6) Cow (dairy) 35 (56.5) 
Hispanic /Latino 4 (6.5) Gout or sheep (dairy) 12 (19.4) 
  Soy yogurt 5 (8.1) 
  Labneh 14 (22.6) 
  Kifir 17 (27.4) 
  Lassi 6 (9.7) 
























Figure 5.2: Preparation of soy protein isolate nanoemulsions (SPNEs) containing VitD3 by using pH 



















Figure 5.3: Triangle test full display. Presentation of samples to participants is done at random and can 




















Figure 5.4: Sample tray showing 3 sets of 9 samples of drinkable yogurt (control and fortified) displayed 
at random. Also shown are water cup (short), rinsing cup (tall), pen, unsalted crackers for rinsing in 






































Figure 5.6: Changes of pH values of the fortified drinkable yogurt samples with SPNEs containing VitD3 
and the control samples over 48 hours stored at 4 and 23 °C. Data points represent means ± SD. Different 
superscripts (a, b, c, d) indicate significant differences across temperature x time interactions (three-way 
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Figure 5.7: Changes of Titratable Acidity (% Lactic Acid) values of the fortified drinkable yogurt 
samples with SPNEs containing VitD3 and the control samples over 48 hours stored at 4 and 23 °C. Data 
points represent means ± SD. Different superscripts (a, b, c, d) indicate significant differences across 
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Figure 5.8: Changes of viscosity values of the fortified drinkable yogurt samples with SPNEs containing 
VitD3 and the control samples over 48 hours stored at 4 and 23 °C. Data points represent means ± SD. 
Different superscripts (a, b, c, d) indicate significant differences across temperature x time interactions 
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Figure 5.9:  Perception of color differences between the fortified yogurt drink with SPNEs containing 
VitD3 and the control samples over 48 hours stored at 4 and 23 °C. ΔE values below 1.0 indicates not 
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CHAPTER 6: SUMMARY AND FUTURE DIRECTIONS 
This dissertation presents several studies that advance the ability to evaluate the stability, 
bioaccessibility, bioavailability, bioefficacy, physicochemical, and sensory characteristics of soy 
protein nanoemulsions (SPNEs) containing vitamin D3 (VitD3). The results showed that the 
dispersion and stabilization of VitD3 in SPNEs resulted in higher protection against UV 
photooxidation, higher bioaccessibility, and higher bioavailability. Also, the consumption of 
VitD3 dispersed in SPNEs and mixed in drinkable yogurt resulted in increased absorption of 
VitD3 represented as 25(OH)D3 in the serum of subjects with VitD3 insufficiency. Moreover, the 
dispersion of VitD3 in SPNEs could protect the vitamin and reduce any potential 
physicochemical and sensory effect on the final product. The findings obtained in this 
dissertation can be used to explore the addition of other micronutrients along with SPNEs as well 
as the nano-emulsification of other fat-soluble vitamins in SPNEs and their addition to yogurt 
and a variety of food products. However, the VitD questionnaire could not identify behaviors 
associated with low VitD3 status; future studies needed to create a valid VitD questionnaire in 
Saudi Arabia with a larger sample size. 
Several pieces of evidence have shown that the encapsulation of lipophilic vitamins 
resulted in protected and stable delivery systems against degradation upon exposure to heat, 
light, and oxygen. Food grade oil-in-water nanoemulsions have shown great potential in 
protecting, stabilizing and delivering lipophilic vitamins. However, several challenges should be 
considered while choosing the appropriate formulation parameters and production methods 
which are essential to developing a successful delivery system for specific lipophilic bioactive 





system or nano-sized delivery system would facilitate the way of producing stable food products 
fortified with nanoemulsions containing micronutrients that would better address nutrient gaps 
worldwide. 
In the future, more research on the effectiveness of nanoemulsions fortified with a variety 
of food products will be helpful to present a wide range of fortified beverages and food to the 
market — more studies needed on formulating different natural ingredients nano-sized with 
lower costs with preventing vitamins from chemical degradation with a longer shelf-life and 
providing increase bioavailability. 
Finally, the experience obtained from these studies can be used to develop a valid VitD 
questionnaire to evaluate the Saudi Arabian behaviors associated with low VitD3 status. Also, to 













































































Appendix I: Research Study Consent Form 
Sensory evaluation of drinkable yogurt fortified with vitamin D3 
 
Dear Participant,  
My name is Nawaf Alruwaili. The objective of this research study is to determine whether 
detectable sensory differences exist between two food products. You will perform a triangle test in 
which you will have to taste a set of drinkable yogurt samples fortified with vitamin D. Before the 
sensory evaluation, you will receive instructions on how to conduct the test. The following are 
some important details that you need to know before considering your participation in this research 
study.  
1. Product. You will evaluate a Mediterranean drinkable yogurt fortified with or without vitamin 
D.  
2. Test time. Depending of your speed, the testing can take between 20 to 30 minutes to complete 
including the initial training and consent process.  
3. Confidentiality. Faculty, students, and staff who may see your information will maintain 
confidentiality to the extent of laws and university policies. Personal identifiers will not be 
published or presented.   
4. Voluntary participation. Participation in this study is voluntary. You can decline to 
participate at any time. You can withdraw from the study at any time and for any reasons 
without any penalties. However, we will ask you to let us know if this is the case. 
5. Benefits and Payments. After you complete the test and submit your answers, you will 
receive a $5. There will be no remuneration for partial participation. Due to University of 
Illinois regulations, we will collect your signature on a document indicating that you received 
this reward. These records will be kept separately from all research data. 
6. Risks. There are no risks associated with this study beyond those that you face daily. 
Nonetheless, we recommend that if you are allergic or intolerant to dairy or soy, you should 
not participate in this study. The amount of vitamin D in the fortified yogurt that you will 
consume provides you with only a fraction of the daily dietary recommendation for a healthy 
population.    
7. Costs. Your participation in this study will have no cost to you.   
8. Photos. There will be not photos taken in this study. 
9. Consent. We look forward to working with you. Your participation in this study is critical and 
will give us insights on consumer taste preference, and will help us in validating and improving 
the product formulations. On the reverse side of this form, please indicate whether you consent 





Appendix I: (cont.): Research Study Consent Form 
If you have any questions about this project, please contact:  
Contact Persons 
 
Dr. Juan E. Andrade  
Assistant Professor and Principal Investigator 
Department of Food Science and Human Nutrition 
University of Illinois, Urbana-Champaign 
Telephone: +01-(217) 333-9653 
E-mail: jandrade@illinois.edu  
Mr. Nawaf Alruwaili, MS, RD 
Doctoral Candidate 
Food Science and Human Nutrition 
University of Illinois Urbana-Champaign 
Telephone: +1(217) 417-2169 
E-mail: Alruwai2@illinois.edu  
 
 
If you have any questions about your rights as a participant in research involving human subjects, 
please feel free to contact the University of Illinois Institutional Review Board (IRB) Office at 





I have read and understood the information provided in this consent form. I certify that I am 18 years 








Date: ……………………………………………………….    
 
 





Appendix J: Sensory Evaluation of Drinkable Yogurt fortified with 
vitamin D 
 
Panelist No:    Date:                /                  / 
 
 
Instructions (read before you start evaluating samples) 
There are 3 sets of samples. Each set, has 3 coded samples. In each set, two samples are identical 
and one is different. Identify the different one by checking the box under the code. 
 
To start: 
1. Please, fill out today’s date. 
2. Evaluate (observe, smell, taste) EACH sample from left to right starting with SET 1.  
3. Write down the codes of each set on the line. 
4. Mark the sample  that you think is the ODD one below its code.  
5. RINSING: After tasting EACH sample of yogurt, please rinse your mouth with water. 
6. When you finish SET 1, please rinse your mouth with water and EAT ONE CRACKER. 
Then, rinse your mouth again before you start SET 2. 
7. Continue with the next sets of samples, following the rinsing instructions (STEPS 4 - 5) 
8. When you finish, turn on the switch to let us know and leave the room. Please talk to one 




     
      
      
Set 2 
     
      
      
Set 3 
     





Appendix K: Demographic Information Questionnaire 
Please read the following questions and mark the option that best fits you. 
1. What is your age in years? 
a)      Less than 18  
b)      18 – 24  
c)       25 – 30  
d)      31 – 45  
e)      Above 45  
 
2. What is your occupation (check all that apply)? 
a)      Farming  
b)      Production (at home, low scale)  
c)       Student  
d)      Office worker (industry, school, private or public sector)  
e)     Other  
 
3. What is your country of origin? _____________________________________________ 
 
4. What is your sex?  Male_____ Female _____ 
 
5. If you are willing, please check your race and ethnicity?  
 American Indian or Alaska Native: A person having origins in any of the original 
peoples of North, Central and South America, and who maintains tribal affiliation or 
community attachment. 
 Asian: A person having origins in any of the original peoples of the Far East, 
Southeast Asia, or the Indian subcontinent including, for example, Cambodia, China, 
India, Japan, Korea, Malaysia, Pakistan, the Philippine Islands, Thailand, and 
Vietnam. 
 Black or African American: A person having origins in any of the black racial 
groups of Africa.  
 Native Hawaiian or Other Pacific Islander: A person having origins in any of the 
original peoples of Hawaii, Guam, Samoa, or other Pacific Islands. 
 White: A person having origins in any of the original peoples of Europe, the Middle 
East, or North Africa.  
 Hispanic or Latino: A person having origins in any of the original peoples of  
Mexico Cuba, Puerto Rico, Dominican Republic, Central or South America. 
 






Appendix K: (cont.): Demographic Information Questionnaire 
6. Have you ever consumed drinkable yogurt or any type of yogurt? If yes, continue with 





7. What types of yogurt do you consume? Check all that apply. 
Low-fat  
Non-fat   
Flavored ones  
Plain (natural) ones  
Whipped types  
Custard types  
Greek types  
Drinkable   
Smoothie types  
Cow (dairy) yogurt  
Goat or sheep yogurt  
Soy yogurt  
Labneh  
Kefir types  
Lassi types  
Chaash types  




8. How often do you consume yogurt? 
a)   Everyday  
b)   Three times a week  
c)   Twice a week  
d)   Once a week  
e)   Once a month   
f)   Twice a month  
 
Thank you for your time.  
Now, please return the questionnaire to one of the researchers and wait for instructions.  
 
